(528926, 'HP:0032166', 'Unusual gastrointestinal infection', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(528927, 'HP:0032166', 'Unusual gastrointestinal infection', 'MP:0005036', 'diarrhea', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(528928, 'HP:0032166', 'Unusual gastrointestinal infection', 'MP:0014206', 'decreased intestinal epithelial sodium ion transmembrane transport', 0.42857142857142855, 9.977790647831666, 2.067896513834253, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(528929, 'HP:0032166', 'Unusual gastrointestinal infection', 'MP:0003292', 'melena', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(528930, 'HP:0032166', 'Unusual gastrointestinal infection', 'MP:0003259', 'nausea', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(528931, 'HP:0032166', 'Unusual gastrointestinal infection', 'MP:0011220', 'increased intestinal calcium absorption', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(528932, 'HP:0032166', 'Unusual gastrointestinal infection', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(528933, 'HP:0032166', 'Unusual gastrointestinal infection', 'MP:0014201', 'abnormal intestinal epithelium physiology', 0.46875, 9.977790647831666, 2.1626579401678607, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(528934, 'HP:0032166', 'Unusual gastrointestinal infection', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(528935, 'HP:0001985', 'Hypoketotic hypoglycemia', 'MP:0000188', 'abnormal circulating glucose level', 0.4375, 13.192109768632433, 2.4024046336486884, 'UPHENO:0051766', 'abnormal blood glucose level'),
(528936, 'HP:0001985', 'Hypoketotic hypoglycemia', 'MP:0013277', 'abnormal fasting circulating glucose level', 0.42857142857142855, 13.192109768632433, 2.3777639347533848, 'UPHENO:0051766', 'abnormal blood glucose level'),
(528937, 'HP:0004590', 'Hypoplastic sacrum', 'MP:0004667', 'vertebral body hypoplasia', 0.423728813559322, 10.555485148088783, 2.1148671821990868, 'UPHENO:0081792', 'bone element hypoplasia in independent continuant'),
(528938, 'HP:0004590', 'Hypoplastic sacrum', 'MP:0000071', 'axial skeleton hypoplasia', 0.43137254901960786, 8.202005804774931, 1.880989141669718, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(528939, 'HP:0100854', 'Aplasia of the musculature', 'MP:0009408', 'decreased skeletal muscle fiber density', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528940, 'HP:0100854', 'Aplasia of the musculature', 'MP:0000734', 'muscle hypoplasia', 0.42857142857142855, 11.716376337666036, 2.2408266654772775, 'UPHENO:0080066', 'aplasia or hypoplasia of muscle organ'),
(528941, 'HP:0100854', 'Aplasia of the musculature', 'MP:0002108', 'abnormal muscle morphology', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528942, 'HP:0100854', 'Aplasia of the musculature', 'MP:0000736', 'delayed muscle development', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528943, 'HP:0100854', 'Aplasia of the musculature', 'MP:0000731', 'increased collagen deposition in the muscles', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528944, 'HP:0100854', 'Aplasia of the musculature', 'MP:0000767', 'abnormal smooth muscle morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528945, 'HP:0100854', 'Aplasia of the musculature', 'MP:0004233', 'abnormal muscle weight', 0.4482758620689655, 7.206267831629091, 1.7973302213347957, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528946, 'HP:0100854', 'Aplasia of the musculature', 'MP:0000752', 'dystrophic muscle', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528947, 'HP:0100854', 'Aplasia of the musculature', 'MP:0003939', 'abnormal myotome morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528948, 'HP:0100854', 'Aplasia of the musculature', 'MP:0021138', 'abnormal multifidus muscle morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528949, 'HP:0100854', 'Aplasia of the musculature', 'MP:0003397', 'increased muscle weight', 0.40625, 7.206267831629091, 1.7110073952497453, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528950, 'HP:0100854', 'Aplasia of the musculature', 'MP:0031112', 'rhabdomyolysis', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528951, 'HP:0100854', 'Aplasia of the musculature', 'MP:0004817', 'abnormal skeletal muscle mass', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528952, 'HP:0100854', 'Aplasia of the musculature', 'MP:0009407', 'increased skeletal muscle fiber density', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528953, 'HP:0100854', 'Aplasia of the musculature', 'MP:0000733', 'abnormal muscle development', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528954, 'HP:0100854', 'Aplasia of the musculature', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528955, 'HP:0100854', 'Aplasia of the musculature', 'MP:0000749', 'muscle degeneration', 0.40625, 7.206267831629091, 1.7110073952497453, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528956, 'HP:0100854', 'Aplasia of the musculature', 'MP:0003199', 'calcified muscle', 0.41935483870967744, 7.206267831629091, 1.7383852519598624, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(528957, 'HP:0009760', 'Antecubital pterygium', 'MP:0002932', 'abnormal joint morphology', 0.40625, 8.414032639097075, 1.8488376780110218, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(528958, 'HP:0009760', 'Antecubital pterygium', 'MP:0002060', 'abnormal skin morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(528959, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004768', 'abnormal axonal transport', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528960, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528961, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0013438', 'dysmyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528962, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0012011', 'febrile seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528963, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528964, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0005402', 'abnormal action potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528965, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0006058', 'decreased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528966, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003472', 'increased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528967, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528968, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0030990', 'nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528969, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003880', 'abnormal central pattern generator function', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528970, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002195', 'psychomotor seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528971, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003471', 'abnormal summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528972, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002634', 'abnormal sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528973, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(528974, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0000921', 'demyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528975, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001496', 'audiogenic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528976, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(528977, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528978, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(528979, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(528980, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0021001', 'impaired neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528981, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528982, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528983, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003481', 'decreased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528984, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528985, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002914', 'abnormal endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528986, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528987, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(528988, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528989, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528990, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002064', 'seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528991, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001499', 'abnormal kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528992, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0010050', 'hypermyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528993, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004513', 'avnosmia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528994, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528995, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003997', 'tonic-clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528996, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528997, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003474', 'abnormal summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(528998, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(528999, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529000, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003464', 'abnormal single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529001, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0000948', 'nonconvulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529002, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529003, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001900', 'impaired synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529004, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529005, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529006, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529007, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003483', 'decreased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529008, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002578', 'impaired ability to fire action potentials', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529009, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0014255', 'increased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529010, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529011, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529012, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0008840', 'abnormal spike wave discharge', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529013, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529014, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003468', 'increased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529015, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0000920', 'abnormal myelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529016, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529017, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0021009', 'abnormal synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529018, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529019, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529020, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529021, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529022, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003216', 'absence seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529023, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529024, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0014120', 'focal seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529025, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004811', 'abnormal neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529026, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529027, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0008814', 'decreased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529028, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003475', 'increased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529029, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003635', 'abnormal synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529030, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0012006', 'abnormal hippocampus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529031, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529032, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003467', 'abnormal single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529033, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529034, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529035, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529036, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529037, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003217', 'increased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529038, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004994', 'abnormal brain wave pattern', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529039, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003484', 'abnormal channel response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529040, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529041, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529042, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003465', 'increased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529043, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0006080', 'brain ischemia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529044, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529045, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529046, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001912', 'increased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529047, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002207', 'abnormal long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529048, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0013806', 'encephalopathy', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529049, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003476', 'decreased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529050, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001500', 'decreased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529051, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003990', 'decreased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529052, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003466', 'decreased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529053, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0008921', 'increased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529054, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529055, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003996', 'clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529056, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529057, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529058, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0005403', 'abnormal nerve conduction', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529059, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529060, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529061, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529062, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529063, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529064, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0014253', 'decreased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529065, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004835', 'abnormal miniature endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529066, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003480', 'increased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529067, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529068, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529069, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003473', 'decreased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529070, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0011397', 'endoneurial edema', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529071, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529072, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002826', 'tonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529073, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0006082', 'CNS inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529074, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529075, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529076, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529077, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529078, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529079, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003889', 'enhanced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529080, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529081, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529082, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529083, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529084, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003486', 'abnormal channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529085, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0000947', 'convulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529086, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529087, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003088', 'abnormal prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529088, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529089, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003469', 'decreased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529090, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529091, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529092, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529093, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003219', 'increased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529094, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529095, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529096, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003463', 'abnormal single cell response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529097, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0020424', 'increased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529098, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529099, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0021010', 'impaired synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529100, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529101, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529102, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529103, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529104, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003470', 'abnormal summary potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529105, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529106, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529107, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0014252', 'abnormal paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529108, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003477', 'abnormal nerve fiber response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529109, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0011994', 'increased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529110, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529111, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529112, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0021015', 'increased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529113, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529114, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529115, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0006060', 'increased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529116, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0004859', 'abnormal synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529117, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0014254', 'increased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529118, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0009358', 'environmentally induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529119, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003485', 'abnormal channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529120, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529121, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529122, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001752', 'abnormal hypothalamus secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529123, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529124, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002915', 'abnormal synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529125, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002635', 'reduced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529126, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529127, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529128, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529129, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529130, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529131, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529132, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002193', 'minimal clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529133, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003633', 'abnormal nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529134, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529135, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529136, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0000951', 'sporadic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529137, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529138, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529139, 'HP:0032699', 'Focal cognitive seizure with dysgraphia/agraphia', 'MP:0003482', 'increased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529140, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0000468', 'abnormal esophageal epithelium morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529141, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0000467', 'abnormal esophagus morphology', 0.46153846153846156, 5.838135946814261, 1.6415006192947488, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529142, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0000462', 'abnormal digestive system morphology', 0.5, 5.838135946814261, 1.7085280136442396, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529143, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0003283', 'abnormal digestive organ placement', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529144, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0010884', 'esophagus stenosis', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529145, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0002138', 'abnormal hepatobiliary system morphology', 0.4444444444444444, 5.838135946814261, 1.6108156590600318, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529146, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0003160', 'abnormal esophagus development', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529147, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0003295', 'lymphomesenteric cyst', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529148, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0003119', 'abnormal digestive system development', 0.48, 5.838135946814261, 1.674008737871713, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529149, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0000477', 'abnormal intestine morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529150, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0003943', 'abnormal hepatobiliary system development', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529151, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0000474', 'abnormal foregut morphology', 0.4444444444444444, 5.838135946814261, 1.6108156590600318, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529152, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0010352', 'gastrointestinal tract polyps', 0.48, 5.838135946814261, 1.674008737871713, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529153, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0014231', 'intestinal mucus accumulation', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529154, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0003301', 'peptic ulcer', 0.46153846153846156, 5.838135946814261, 1.6415006192947488, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529155, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0008786', 'abnormal hindgut morphology', 0.4444444444444444, 5.838135946814261, 1.6108156590600318, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529156, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0004547', 'esophageal ulcer', 0.4444444444444444, 5.838135946814261, 1.6108156590600318, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529157, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0009705', 'abnormal midgut morphology', 0.4444444444444444, 5.838135946814261, 1.6108156590600318, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529158, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0003300', 'gastrointestinal ulcer', 0.48, 5.838135946814261, 1.674008737871713, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529159, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0003294', 'intussusception', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529160, 'HP:0034866', 'Positive stool infectious agent test', 'MP:0003262', 'intestinal/bowel diverticulum', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(529161, 'HP:0034239', 'Renal vein thrombosis', 'MP:0002829', 'abnormal juxtaglomerular apparatus morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529162, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011767', 'ureterocele', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(529163, 'HP:0034239', 'Renal vein thrombosis', 'MP:0004192', 'abnormal kidney pyramid morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529164, 'HP:0034239', 'Renal vein thrombosis', 'MP:0012025', 'abnormal comma shaped body morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529165, 'HP:0034239', 'Renal vein thrombosis', 'MP:0003985', 'renal fibrosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529166, 'HP:0034239', 'Renal vein thrombosis', 'MP:0003881', 'abnormal nephron morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529167, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011382', 'abnormal kidney lobule morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529168, 'HP:0034239', 'Renal vein thrombosis', 'MP:0003942', 'abnormal urinary system development', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(529169, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011378', 'abnormal kidney outer medulla inner stripe morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529170, 'HP:0034239', 'Renal vein thrombosis', 'MP:0002956', 'decreased compensatory renal growth', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529171, 'HP:0034239', 'Renal vein thrombosis', 'MP:0008487', 'abnormal mesonephros morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529172, 'HP:0034239', 'Renal vein thrombosis', 'MP:0003600', 'ectopic kidney', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529173, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011364', 'abnormal metanephros morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529174, 'HP:0034239', 'Renal vein thrombosis', 'MP:0005360', 'urolithiasis', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(529175, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529176, 'HP:0034239', 'Renal vein thrombosis', 'MP:0012024', 'abnormal nephron morphogenesis', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529177, 'HP:0034239', 'Renal vein thrombosis', 'MP:0002955', 'increased compensatory renal growth', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529178, 'HP:0034239', 'Renal vein thrombosis', 'MP:0031002', 'abnormal kidney glycogen level', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529179, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011383', 'abnormal kidney capsule morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529180, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011337', 'abnormal perihilar interstitium morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529181, 'HP:0034239', 'Renal vein thrombosis', 'MP:0000534', 'abnormal ureter morphology', 0.41935483870967744, 7.390401409715969, 1.7604546546762325, 'UPHENO:0087427', 'abnormal renal system morphology'),
(529182, 'HP:0034239', 'Renal vein thrombosis', 'MP:0004755', 'abnormal loop of Henle morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529183, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011402', 'renal cast', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529184, 'HP:0034239', 'Renal vein thrombosis', 'MP:0009860', 'nephrosclerosis', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529185, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011379', 'abnormal kidney outer medulla outer stripe morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529186, 'HP:0034239', 'Renal vein thrombosis', 'MP:0000521', 'abnormal kidney cortex morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529187, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011534', 'granular kidney', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529188, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011347', 'abnormal kidney medullary ray morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529189, 'HP:0034239', 'Renal vein thrombosis', 'MP:0002706', 'abnormal kidney size', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529190, 'HP:0034239', 'Renal vein thrombosis', 'MP:0003613', 'abnormal kidney medulla development', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529191, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011361', 'pelvic kidney', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529192, 'HP:0034239', 'Renal vein thrombosis', 'MP:0003197', 'nephrocalcinosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529193, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011797', 'blind ureter', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(529194, 'HP:0034239', 'Renal vein thrombosis', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529195, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529196, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011333', 'abnormal kidney inner medulla morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529197, 'HP:0034239', 'Renal vein thrombosis', 'MP:0004195', 'abnormal kidney calyx morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529198, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011332', 'abnormal kidney outer medulla morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529199, 'HP:0034239', 'Renal vein thrombosis', 'MP:0009640', 'abnormal renal tubule epithelium morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529200, 'HP:0034239', 'Renal vein thrombosis', 'MP:0002135', 'abnormal kidney morphology', 0.5172413793103449, 7.667568053596582, 1.9914777116498774, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529201, 'HP:0034239', 'Renal vein thrombosis', 'MP:0004754', 'abnormal kidney collecting duct morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529202, 'HP:0034239', 'Renal vein thrombosis', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529203, 'HP:0034239', 'Renal vein thrombosis', 'MP:0003014', 'abnormal kidney medulla morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529204, 'HP:0034239', 'Renal vein thrombosis', 'MP:0003675', 'kidney cyst', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529205, 'HP:0034239', 'Renal vein thrombosis', 'MP:0000527', 'abnormal kidney development', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529206, 'HP:0034239', 'Renal vein thrombosis', 'MP:0002703', 'abnormal renal tubule morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529207, 'HP:0034239', 'Renal vein thrombosis', 'MP:0004969', 'pale kidney', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529208, 'HP:0034239', 'Renal vein thrombosis', 'MP:0008528', 'polycystic kidney', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529209, 'HP:0034239', 'Renal vein thrombosis', 'MP:0009641', 'kidney degeneration', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529210, 'HP:0034239', 'Renal vein thrombosis', 'MP:0012026', 'abnormal S-shaped body morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529211, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011381', 'abnormal kidney lobe morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529212, 'HP:0034239', 'Renal vein thrombosis', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529213, 'HP:0034239', 'Renal vein thrombosis', 'MP:0011334', 'abnormal nephrogenic zone morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(529214, 'HP:0034239', 'Renal vein thrombosis', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42857142857142855, 7.390401409715969, 1.7796951676841382, 'UPHENO:0087427', 'abnormal renal system morphology'),
(529215, 'HP:0040305', 'Increased male libido', 'MP:0003698', 'abnormal male reproductive system physiology', 0.42105263157894735, 11.073168695908924, 2.1592560800725034, 'UPHENO:0002371', 'abnormality of male reproductive system physiology'),
(529216, 'HP:0004802', 'Episodic hemolytic anemia', 'MP:0013658', 'abnormal myeloid cell morphology', 0.4358974358974359, 9.052558416233639, 1.9864508556589051, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(529217, 'HP:0004802', 'Episodic hemolytic anemia', 'MP:0002447', 'abnormal erythrocyte morphology', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(529218, 'HP:0004802', 'Episodic hemolytic anemia', 'MP:0000358', 'abnormal cell morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(529219, 'HP:0004802', 'Episodic hemolytic anemia', 'MP:0002424', 'abnormal reticulocyte morphology', 0.4186046511627907, 10.15319077934013, 2.0615947430023533, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(529220, 'HP:0004802', 'Episodic hemolytic anemia', 'MP:0013659', 'abnormal erythroid lineage cell morphology', 0.43902439024390244, 10.15319077934013, 2.111278852006483, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(529221, 'HP:0004802', 'Episodic hemolytic anemia', 'MP:0013656', 'abnormal hematopoietic cell morphology', 0.42105263157894735, 7.94655706237675, 1.8291852730398854, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(529222, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529223, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529224, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529225, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529226, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529227, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529228, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529229, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529230, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0000428', 'abnormal craniofacial morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529231, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529232, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529233, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529234, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529235, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529236, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529237, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529238, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529239, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529240, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529241, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529242, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529243, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529244, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529245, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529246, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529247, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529248, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529249, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529250, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529251, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529252, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529253, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529254, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0002109', 'abnormal limb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529255, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529256, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529257, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529258, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529259, 'HP:0030926', '5-minute APGAR score of 6', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(529260, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0002968', 'increased circulating alkaline phosphatase level', 0.42105263157894735, 11.397693902282326, 2.190668622016414, 'UPHENO:0068533', 'increased level of protein in blood'),
(529261, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0003352', 'increased circulating renin level', 0.43010752688172044, 11.397693902282326, 2.2140988994318924, 'UPHENO:0068533', 'increased level of protein in blood'),
(529262, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0000332', 'hemoglobinemia', 0.5, 15.87018167374507, 2.816929327631869, 'UPHENO:0068336', 'increased level of hemoglobin in blood'),
(529263, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0005522', 'increased circulating atrial natriuretic factor', 0.41304347826086957, 11.397693902282326, 2.169733424536617, 'UPHENO:0068533', 'increased level of protein in blood'),
(529264, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0006375', 'increased circulating angiotensinogen level', 0.4166666666666667, 11.397693902282326, 2.1792290209959506, 'UPHENO:0068533', 'increased level of protein in blood'),
(529265, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0004731', 'increased circulating gastrin level', 0.41304347826086957, 11.397693902282326, 2.169733424536617, 'UPHENO:0068533', 'increased level of protein in blood'),
(529266, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0005564', 'increased hemoglobin content', 0.51, 15.87018167374507, 2.844959165543503, 'UPHENO:0068336', 'increased level of hemoglobin in blood'),
(529267, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0004702', 'increased circulating insulin-like growth factor I level', 0.40425531914893614, 11.397693902282326, 2.146527052247193, 'UPHENO:0068533', 'increased level of protein in blood'),
(529268, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0002712', 'increased circulating glucagon level', 0.40860215053763443, 11.397693902282326, 2.1580366631830517, 'UPHENO:0068533', 'increased level of protein in blood'),
(529269, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0002904', 'increased circulating parathyroid hormone level', 0.41304347826086957, 11.397693902282326, 2.169733424536617, 'UPHENO:0068533', 'increased level of protein in blood'),
(529270, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0005343', 'increased circulating aspartate transaminase level', 0.43010752688172044, 11.397693902282326, 2.2140988994318924, 'UPHENO:0068533', 'increased level of protein in blood'),
(529271, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0011009', 'increased circulating glutamate dehydrogenase level', 0.43010752688172044, 11.397693902282326, 2.2140988994318924, 'UPHENO:0068533', 'increased level of protein in blood'),
(529272, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0005669', 'increased circulating leptin level', 0.41304347826086957, 11.397693902282326, 2.169733424536617, 'UPHENO:0068533', 'increased level of protein in blood'),
(529273, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0001754', 'increased circulating corticotropin-releasing hormone level', 0.42696629213483145, 11.397693902282326, 2.20599889037716, 'UPHENO:0068533', 'increased level of protein in blood'),
(529274, 'HP:0001900', 'Increased circulating hemoglobin concentration', 'MP:0002079', 'increased circulating insulin level', 0.40860215053763443, 11.397693902282326, 2.1580366631830517, 'UPHENO:0068533', 'increased level of protein in blood'),
(529275, 'HP:0410275', 'Lumbosacral hemangioma', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4074074074074074, 7.347404004220494, 1.7301406926993756, 'UPHENO:0080362', 'abnormal cardiovascular system'),
(529276, 'HP:0031405', 'Poroma', 'MP:0001211', 'wrinkled skin', 0.4166666666666667, 6.904974582545727, 1.6961936041405727, 'UPHENO:0003811', 'abnormal skin of body'),
(529277, 'HP:0031405', 'Poroma', 'MP:0001197', 'oily skin', 0.40540540540540543, 6.904974582545727, 1.6731150647672055, 'UPHENO:0003811', 'abnormal skin of body'),
(529278, 'HP:0031405', 'Poroma', 'MP:0009932', 'skin fibrosis', 0.42857142857142855, 6.904974582545727, 1.7202542896592428, 'UPHENO:0003811', 'abnormal skin of body'),
(529279, 'HP:0031405', 'Poroma', 'MP:0003196', 'calcified skin', 0.42857142857142855, 6.904974582545727, 1.7202542896592428, 'UPHENO:0003811', 'abnormal skin of body'),
(529280, 'HP:0031405', 'Poroma', 'MP:0000367', 'abnormal coat/ hair morphology', 0.42424242424242425, 8.50911518495075, 1.89998096154186, 'UPHENO:0086842', 'abnormal integumentary adnexa morphology'),
(529281, 'HP:0002470', 'Nonprogressive cerebellar ataxia', 'MP:0001442', 'decreased grooming behavior', 0.4186046511627907, 10.749166272783702, 2.121238081383006, 'UPHENO:0074360', 'abnormally decreased rate of behavior process'),
(529282, 'HP:0002470', 'Nonprogressive cerebellar ataxia', 'MP:0003158', 'dysphagia', 0.43137254901960786, 10.749166272783702, 2.1533451314005156, 'UPHENO:0074360', 'abnormally decreased rate of behavior process'),
(529283, 'HP:0002470', 'Nonprogressive cerebellar ataxia', 'MP:0001405', 'impaired coordination', 0.425531914893617, 13.548253578857707, 2.4010860644457583, 'UPHENO:0080275', 'decreased motor coordination'),
(529284, 'HP:0002470', 'Nonprogressive cerebellar ataxia', 'MP:0009747', 'impaired behavioral response to xenobiotic', 0.4090909090909091, 10.749166272783702, 2.096994564251997, 'UPHENO:0074360', 'abnormally decreased rate of behavior process'),
(529285, 'HP:0002470', 'Nonprogressive cerebellar ataxia', 'MP:0020351', 'decreased vocalization', 0.4186046511627907, 10.749166272783702, 2.121238081383006, 'UPHENO:0074360', 'abnormally decreased rate of behavior process'),
(529286, 'HP:0025007', 'Ectopic fovea', 'MP:0001329', 'retina hyperplasia', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(529287, 'HP:0025007', 'Ectopic fovea', 'MP:0006188', 'calcified retina', 0.417910447761194, 9.356059413574362, 1.9773707236649367, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(529288, 'HP:0025007', 'Ectopic fovea', 'MP:0020443', 'tractional retina detachment', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(529289, 'HP:0025007', 'Ectopic fovea', 'MP:0020038', 'retina macular degeneration', 0.4117647058823529, 12.083585311854263, 2.230603943316695, 'UPHENO:0076777', 'abnormal macula lutea morphology'),
(529290, 'HP:0025007', 'Ectopic fovea', 'MP:0020442', 'serous retina detachment', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(529291, 'HP:0025007', 'Ectopic fovea', 'MP:0001326', 'retina degeneration', 0.4153846153846154, 9.356059413574362, 1.9713860963857883, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(529292, 'HP:0025007', 'Ectopic fovea', 'MP:0003099', 'retina detachment', 0.4090909090909091, 9.356059413574362, 1.9563943495644465, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(529293, 'HP:0025007', 'Ectopic fovea', 'MP:0006186', 'retina fibrosis', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(529294, 'HP:0025007', 'Ectopic fovea', 'MP:0020441', 'rhegmatogenous retina detachment', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(529295, 'HP:0040262', 'Glue ear', 'MP:0006033', 'abnormal external auditory canal morphology', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(529296, 'HP:0040262', 'Glue ear', 'MP:0030178', 'abnormal scalp morphology', 0.42424242424242425, 4.6730878730104815, 1.4080206418742023, 'UPHENO:0087907', 'abnormal head morphology'),
(529297, 'HP:0040262', 'Glue ear', 'MP:0002102', 'abnormal ear morphology', 0.5, 7.8051695233081215, 1.975496079888305, 'UPHENO:0076730', 'abnormal ear morphology'),
(529298, 'HP:0040262', 'Glue ear', 'MP:0030187', 'abnormal epitympanic recess morphology', 0.4594594594594595, 9.948935785159481, 2.138020733773704, 'UPHENO:0003017', 'abnormal middle ear'),
(529299, 'HP:0040262', 'Glue ear', 'MP:0030410', 'middle ear effusion', 0.4146341463414634, 9.948935785159481, 2.0310510816534473, 'UPHENO:0003017', 'abnormal middle ear'),
(529300, 'HP:0040262', 'Glue ear', 'MP:0020305', 'abnormal horn pigmentation', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(529301, 'HP:0040262', 'Glue ear', 'MP:0030413', 'tympanic membrane retraction', 0.4473684210526316, 9.948935785159481, 2.109701327999018, 'UPHENO:0003017', 'abnormal middle ear'),
(529302, 'HP:0040262', 'Glue ear', 'MP:0013097', 'ear wound', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(529303, 'HP:0040262', 'Glue ear', 'MP:0030092', 'abnormal outer ear helix morphology', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(529304, 'HP:0040262', 'Glue ear', 'MP:0000035', 'abnormal membranous labyrinth morphology', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(529305, 'HP:0040262', 'Glue ear', 'MP:0000049', 'abnormal middle ear morphology', 0.5, 9.948935785159481, 2.2303515177163757, 'UPHENO:0003017', 'abnormal middle ear'),
(529306, 'HP:0040262', 'Glue ear', 'MP:0000026', 'abnormal inner ear morphology', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(529307, 'HP:0040262', 'Glue ear', 'MP:0020900', 'abnormal middle ear epithelium morphology', 0.4722222222222222, 9.948935785159481, 2.1675120680665656, 'UPHENO:0003017', 'abnormal middle ear'),
(529308, 'HP:0040262', 'Glue ear', 'MP:0003938', 'abnormal ear development', 0.48484848484848486, 7.8051695233081215, 1.9453340631782279, 'UPHENO:0076730', 'abnormal ear morphology'),
(529309, 'HP:0040262', 'Glue ear', 'MP:0006018', 'abnormal tympanic membrane morphology', 0.4594594594594595, 9.948935785159481, 2.138020733773704, 'UPHENO:0003017', 'abnormal middle ear'),
(529310, 'HP:0040262', 'Glue ear', 'MP:0030160', 'abnormal auditory bulla morphology', 0.48484848484848486, 7.8051695233081215, 1.9453340631782279, 'UPHENO:0076730', 'abnormal ear morphology'),
(529311, 'HP:0040262', 'Glue ear', 'MP:0003677', 'abnormal ear lobe morphology', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(529312, 'HP:0040262', 'Glue ear', 'MP:0000432', 'abnormal head morphology', 0.4666666666666667, 4.6730878730104815, 1.4767445076038797, 'UPHENO:0087907', 'abnormal head morphology'),
(529313, 'HP:0040262', 'Glue ear', 'MP:0003330', 'abnormal auditory tube morphology', 0.4722222222222222, 9.948935785159481, 2.1675120680665656, 'UPHENO:0003017', 'abnormal middle ear'),
(529314, 'HP:0040262', 'Glue ear', 'MP:0030161', 'absent auditory bulla', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(529315, 'HP:0040262', 'Glue ear', 'MP:0013114', 'greasy head/neck', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(529316, 'HP:0040262', 'Glue ear', 'MP:0030154', 'abnormal tympanic cavity morphology', 0.4722222222222222, 9.948935785159481, 2.1675120680665656, 'UPHENO:0003017', 'abnormal middle ear'),
(529317, 'HP:0040262', 'Glue ear', 'MP:0030227', 'abnormal tubotympanic recess morphology', 0.4857142857142857, 9.948935785159481, 2.1982584558022364, 'UPHENO:0003017', 'abnormal middle ear'),
(529318, 'HP:0040262', 'Glue ear', 'MP:0003737', 'ossification of pinnae', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(529319, 'HP:0040262', 'Glue ear', 'MP:0002859', 'abnormal inner ear canal fusion', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(529320, 'HP:0040262', 'Glue ear', 'MP:0020290', 'floppy ears', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(529321, 'HP:0040262', 'Glue ear', 'MP:0030228', 'absent tubotympanic recess', 0.4722222222222222, 9.948935785159481, 2.1675120680665656, 'UPHENO:0003017', 'abnormal middle ear'),
(529322, 'HP:0040262', 'Glue ear', 'MP:0000020', 'scaly ears', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(529323, 'HP:0040262', 'Glue ear', 'MP:0003743', 'abnormal facial morphology', 0.42424242424242425, 4.6730878730104815, 1.4080206418742023, 'UPHENO:0087907', 'abnormal head morphology'),
(529324, 'HP:0040262', 'Glue ear', 'MP:0012176', 'abnormal head development', 0.45161290322580644, 4.6730878730104815, 1.4527308014080145, 'UPHENO:0087907', 'abnormal head morphology'),
(529325, 'HP:0040262', 'Glue ear', 'MP:0002729', 'abnormal inner ear canal morphology', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(529326, 'HP:0040262', 'Glue ear', 'MP:0020304', 'abnormal horn morphology', 0.4375, 4.6730878730104815, 1.4298517211382744, 'UPHENO:0087907', 'abnormal head morphology'),
(529327, 'HP:0040262', 'Glue ear', 'MP:0030324', 'abnormal anterior head development', 0.4375, 4.6730878730104815, 1.4298517211382744, 'UPHENO:0087907', 'abnormal head morphology'),
(529328, 'HP:0040262', 'Glue ear', 'MP:0030226', 'middle ear polyps', 0.4857142857142857, 9.948935785159481, 2.1982584558022364, 'UPHENO:0003017', 'abnormal middle ear'),
(529329, 'HP:0040262', 'Glue ear', 'MP:0030321', 'abnormal tegmen tympani morphology', 0.4594594594594595, 9.948935785159481, 2.138020733773704, 'UPHENO:0003017', 'abnormal middle ear'),
(529330, 'HP:0040262', 'Glue ear', 'MP:0003935', 'abnormal craniofacial development', 0.41379310344827586, 4.656469875639396, 1.3880976626139216, 'UPHENO:0086589', 'abnormal craniocervical region morphology'),
(529331, 'HP:0040262', 'Glue ear', 'MP:0003682', 'linear crease in ear lobe', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(529332, 'HP:0040262', 'Glue ear', 'MP:0002177', 'abnormal outer ear morphology', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(529333, 'HP:0040262', 'Glue ear', 'MP:0000428', 'abnormal craniofacial morphology', 0.42857142857142855, 4.656469875639396, 1.4126676702970866, 'UPHENO:0086589', 'abnormal craniocervical region morphology'),
(529334, 'HP:0040262', 'Glue ear', 'MP:0011238', 'abnormal inner ear development', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(529335, 'HP:0009830', 'Peripheral neuropathy', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529336, 'HP:0009830', 'Peripheral neuropathy', 'MP:0011904', 'abnormal Schwann cell physiology', 0.425, 7.291997705654976, 1.7604258078383663, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529337, 'HP:0009830', 'Peripheral neuropathy', 'MP:0020371', 'abnormal glymphatic system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529338, 'HP:0009830', 'Peripheral neuropathy', 'MP:0002751', 'abnormal autonomic nervous system morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(529339, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003632', 'abnormal nervous system morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(529340, 'HP:0009830', 'Peripheral neuropathy', 'MP:0008814', 'decreased nerve conduction velocity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529341, 'HP:0009830', 'Peripheral neuropathy', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529342, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003471', 'abnormal summary potential threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529343, 'HP:0009830', 'Peripheral neuropathy', 'MP:0000948', 'nonconvulsive seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529344, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003880', 'abnormal central pattern generator function', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529345, 'HP:0009830', 'Peripheral neuropathy', 'MP:0000951', 'sporadic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529346, 'HP:0009830', 'Peripheral neuropathy', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529347, 'HP:0009830', 'Peripheral neuropathy', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529348, 'HP:0009830', 'Peripheral neuropathy', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4411764705882353, 7.291997705654976, 1.793615848312668, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529349, 'HP:0009830', 'Peripheral neuropathy', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529350, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003635', 'abnormal synaptic transmission', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529351, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003477', 'abnormal nerve fiber response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529352, 'HP:0009830', 'Peripheral neuropathy', 'MP:0013438', 'dysmyelination', 0.48484848484848486, 7.291997705654976, 1.8802962636524712, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529353, 'HP:0009830', 'Peripheral neuropathy', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4411764705882353, 7.291997705654976, 1.793615848312668, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529354, 'HP:0009830', 'Peripheral neuropathy', 'MP:0011994', 'increased nerve conduction velocity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529355, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003482', 'increased nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529356, 'HP:0009830', 'Peripheral neuropathy', 'MP:0000920', 'abnormal myelination', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529357, 'HP:0009830', 'Peripheral neuropathy', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529358, 'HP:0009830', 'Peripheral neuropathy', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529359, 'HP:0009830', 'Peripheral neuropathy', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.46875, 7.291997705654976, 1.8488168985937385, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529360, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003481', 'decreased nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529361, 'HP:0009830', 'Peripheral neuropathy', 'MP:0001051', 'abnormal somatic motor system morphology', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(529362, 'HP:0009830', 'Peripheral neuropathy', 'MP:0021015', 'increased tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529363, 'HP:0009830', 'Peripheral neuropathy', 'MP:0021010', 'impaired synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529364, 'HP:0009830', 'Peripheral neuropathy', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.46875, 7.291997705654976, 1.8488168985937385, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529365, 'HP:0009830', 'Peripheral neuropathy', 'MP:0011397', 'endoneurial edema', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529366, 'HP:0009830', 'Peripheral neuropathy', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529367, 'HP:0009830', 'Peripheral neuropathy', 'MP:0014120', 'focal seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529368, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003889', 'enhanced sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529369, 'HP:0009830', 'Peripheral neuropathy', 'MP:0001033', 'abnormal parasympathetic system morphology', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(529370, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529371, 'HP:0009830', 'Peripheral neuropathy', 'MP:0011399', 'increased endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529372, 'HP:0009830', 'Peripheral neuropathy', 'MP:0000959', 'abnormal somatic sensory system morphology', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(529373, 'HP:0009830', 'Peripheral neuropathy', 'MP:0001044', 'abnormal enteric nervous system morphology', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(529374, 'HP:0009830', 'Peripheral neuropathy', 'MP:0005402', 'abnormal action potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529375, 'HP:0009830', 'Peripheral neuropathy', 'MP:0002578', 'impaired ability to fire action potentials', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529376, 'HP:0009830', 'Peripheral neuropathy', 'MP:0001007', 'abnormal sympathetic system morphology', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(529377, 'HP:0009830', 'Peripheral neuropathy', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529378, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003996', 'clonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529379, 'HP:0009830', 'Peripheral neuropathy', 'MP:0001752', 'abnormal hypothalamus secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529380, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003472', 'increased summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529381, 'HP:0009830', 'Peripheral neuropathy', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529382, 'HP:0009830', 'Peripheral neuropathy', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529383, 'HP:0009830', 'Peripheral neuropathy', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529384, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003473', 'decreased summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529385, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529386, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003480', 'increased nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529387, 'HP:0009830', 'Peripheral neuropathy', 'MP:0002826', 'tonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529388, 'HP:0009830', 'Peripheral neuropathy', 'MP:0004859', 'abnormal synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529389, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003474', 'abnormal summary potential intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529390, 'HP:0009830', 'Peripheral neuropathy', 'MP:0013915', 'abnormal brachial plexus formation', 0.42424242424242425, 7.61846258113911, 1.7977972728933185, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(529391, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003463', 'abnormal single cell response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529392, 'HP:0009830', 'Peripheral neuropathy', 'MP:0010050', 'hypermyelination', 0.48484848484848486, 7.291997705654976, 1.8802962636524712, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529393, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003465', 'increased single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529394, 'HP:0009830', 'Peripheral neuropathy', 'MP:0000921', 'demyelination', 0.48484848484848486, 7.291997705654976, 1.8802962636524712, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529395, 'HP:0009830', 'Peripheral neuropathy', 'MP:0002635', 'reduced sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529396, 'HP:0009830', 'Peripheral neuropathy', 'MP:0000958', 'peripheral nervous system degeneration', 0.40540540540540543, 7.61846258113911, 1.757431623498511, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(529397, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003476', 'decreased summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529398, 'HP:0009830', 'Peripheral neuropathy', 'MP:0000947', 'convulsive seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529399, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003997', 'tonic-clonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529400, 'HP:0009830', 'Peripheral neuropathy', 'MP:0002752', 'abnormal somatic nervous system morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(529401, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003412', 'abnormal afterhyperpolarization', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529402, 'HP:0009830', 'Peripheral neuropathy', 'MP:0013806', 'encephalopathy', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529403, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529404, 'HP:0009830', 'Peripheral neuropathy', 'MP:0005623', 'abnormal meninges morphology', 0.41935483870967744, 5.028460092616607, 1.4521394805931305, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(529405, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003216', 'absence seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529406, 'HP:0009830', 'Peripheral neuropathy', 'MP:0012011', 'febrile seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529407, 'HP:0009830', 'Peripheral neuropathy', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529408, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003466', 'decreased single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529409, 'HP:0009830', 'Peripheral neuropathy', 'MP:0021009', 'abnormal synaptic physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529410, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003464', 'abnormal single cell response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529411, 'HP:0009830', 'Peripheral neuropathy', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529412, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003483', 'decreased nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529413, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529414, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003467', 'abnormal single cell response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529415, 'HP:0009830', 'Peripheral neuropathy', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529416, 'HP:0009830', 'Peripheral neuropathy', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529417, 'HP:0009830', 'Peripheral neuropathy', 'MP:0005403', 'abnormal nerve conduction', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529418, 'HP:0009830', 'Peripheral neuropathy', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529419, 'HP:0009830', 'Peripheral neuropathy', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529420, 'HP:0009830', 'Peripheral neuropathy', 'MP:0021016', 'decreased tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529421, 'HP:0009830', 'Peripheral neuropathy', 'MP:0009358', 'environmentally induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529422, 'HP:0009830', 'Peripheral neuropathy', 'MP:0004994', 'abnormal brain wave pattern', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529423, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003470', 'abnormal summary potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529424, 'HP:0009830', 'Peripheral neuropathy', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529425, 'HP:0009830', 'Peripheral neuropathy', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529426, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003468', 'increased single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529427, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003690', 'abnormal glial cell physiology', 0.42105263157894735, 7.291997705654976, 1.7522313841024746, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529428, 'HP:0009830', 'Peripheral neuropathy', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529429, 'HP:0009830', 'Peripheral neuropathy', 'MP:0004513', 'avnosmia', 0.45454545454545453, 7.291997705654976, 1.8205890287655127, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529430, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003633', 'abnormal nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529431, 'HP:0009830', 'Peripheral neuropathy', 'MP:0012006', 'abnormal hippocampus physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529432, 'HP:0009830', 'Peripheral neuropathy', 'MP:0006080', 'brain ischemia', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529433, 'HP:0009830', 'Peripheral neuropathy', 'MP:0002634', 'abnormal sensorimotor gating', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529434, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003469', 'decreased single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529435, 'HP:0009830', 'Peripheral neuropathy', 'MP:0001912', 'increased cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529436, 'HP:0009830', 'Peripheral neuropathy', 'MP:0002064', 'seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529437, 'HP:0009830', 'Peripheral neuropathy', 'MP:0003475', 'increased summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529438, 'HP:0011873', 'Abnormal platelet count', 'MP:0004720', 'abnormal platelet morphology', 0.45652173913043476, 12.002285209752415, 2.3407913442884367, 'UPHENO:0084987', 'abnormal platelet morphology'),
(529439, 'HP:0011873', 'Abnormal platelet count', 'MP:0011181', 'increased hematopoietic cell number', 0.40425531914893614, 8.384754846574827, 1.8410816783857515, 'UPHENO:0086045', 'abnormal number of anatomical enitites of type hematopoietic cell'),
(529440, 'HP:0011873', 'Abnormal platelet count', 'MP:0001586', 'abnormal erythrocyte cell number', 0.41818181818181815, 10.175301480945878, 2.062795693676447, 'UPHENO:0086005', 'abnormal number of anatomical enitites of type myeloid cell'),
(529441, 'HP:0011873', 'Abnormal platelet count', 'MP:0002586', 'abnormal platelet volume', 0.44680851063829785, 12.002285209752415, 2.3157554229291026, 'UPHENO:0084987', 'abnormal platelet morphology'),
(529442, 'HP:0011873', 'Abnormal platelet count', 'MP:0013657', 'abnormal blood cell morphology', 0.4090909090909091, 9.749166272783702, 1.9970716795877694, 'UPHENO:0085070', 'abnormal blood cell morphology'),
(529443, 'HP:0011873', 'Abnormal platelet count', 'MP:0013663', 'increased myeloid cell number', 0.4117647058823529, 10.175301480945878, 2.046907428675256, 'UPHENO:0086005', 'abnormal number of anatomical enitites of type myeloid cell'),
(529444, 'HP:0011873', 'Abnormal platelet count', 'MP:0011180', 'abnormal hematopoietic cell number', 0.4418604651162791, 8.384754846574827, 1.924809516911616, 'UPHENO:0086045', 'abnormal number of anatomical enitites of type hematopoietic cell'),
(529445, 'HP:0011873', 'Abnormal platelet count', 'MP:0003405', 'abnormal platelet shape', 0.4117647058823529, 12.002285209752415, 2.223087366549011, 'UPHENO:0084987', 'abnormal platelet morphology'),
(529446, 'HP:0011873', 'Abnormal platelet count', 'MP:0011898', 'abnormal platelet cell number', 0.5306122448979592, 13.548253578857707, 2.68120667721168, 'UPHENO:0086049', 'abnormal number of anatomical enitites of type platelet'),
(529447, 'HP:0011873', 'Abnormal platelet count', 'MP:0011182', 'decreased hematopoietic cell number', 0.40425531914893614, 8.384754846574827, 1.8410816783857515, 'UPHENO:0086045', 'abnormal number of anatomical enitites of type hematopoietic cell'),
(529448, 'HP:0011873', 'Abnormal platelet count', 'MP:0013661', 'abnormal myeloid cell number', 0.4666666666666667, 10.175301480945878, 2.179099360846451, 'UPHENO:0086005', 'abnormal number of anatomical enitites of type myeloid cell'),
(529449, 'HP:0011873', 'Abnormal platelet count', 'MP:0003179', 'thrombocytopenia', 0.45614035087719296, 13.548253578857707, 2.485941499962004, 'UPHENO:0086049', 'abnormal number of anatomical enitites of type platelet'),
(529450, 'HP:0011873', 'Abnormal platelet count', 'MP:0011913', 'abnormal reticulocyte cell number', 0.40384615384615385, 10.175301480945878, 2.0271300814957747, 'UPHENO:0086005', 'abnormal number of anatomical enitites of type myeloid cell'),
(529451, 'HP:0011873', 'Abnormal platelet count', 'MP:0013662', 'decreased myeloid cell number', 0.4117647058823529, 10.175301480945878, 2.046907428675256, 'UPHENO:0086005', 'abnormal number of anatomical enitites of type myeloid cell'),
(529452, 'HP:0011873', 'Abnormal platelet count', 'MP:0005505', 'thrombocytosis', 0.45614035087719296, 13.548253578857707, 2.485941499962004, 'UPHENO:0086049', 'abnormal number of anatomical enitites of type platelet'),
(529453, 'HP:0011873', 'Abnormal platelet count', 'MP:0013708', 'abnormal hematopoietic precursor cell number', 0.40425531914893614, 8.384754846574827, 1.8410816783857515, 'UPHENO:0086045', 'abnormal number of anatomical enitites of type hematopoietic cell'),
(529454, 'HP:0040332', 'Multifocal hypointensity of cerebral white matter on MRI', 'MP:0020573', 'abnormal corpus callosum size', 0.40350877192982454, 10.963291078136551, 2.103279372610325, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(529455, 'HP:0040332', 'Multifocal hypointensity of cerebral white matter on MRI', 'MP:0000791', 'delaminated cerebral cortex', 0.42, 8.700256672302757, 1.9115720761632709, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(529456, 'HP:0040332', 'Multifocal hypointensity of cerebral white matter on MRI', 'MP:0020140', 'increased brain external capsule size', 0.4339622641509434, 10.963291078136551, 2.1812048548483416, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(529457, 'HP:0040332', 'Multifocal hypointensity of cerebral white matter on MRI', 'MP:0020066', 'abnormal neocortex size', 0.40384615384615385, 8.700256672302757, 1.8744506380760753, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(529458, 'HP:0040332', 'Multifocal hypointensity of cerebral white matter on MRI', 'MP:0020569', 'abnormal premotor cortex size', 0.40384615384615385, 8.700256672302757, 1.8744506380760753, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(529459, 'HP:0040332', 'Multifocal hypointensity of cerebral white matter on MRI', 'MP:0012462', 'decreased brain internal capsule size', 0.42592592592592593, 10.963291078136551, 2.1609141361124817, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(529460, 'HP:0040332', 'Multifocal hypointensity of cerebral white matter on MRI', 'MP:0012137', 'abnormal forebrain size', 0.4166666666666667, 9.371930806217245, 1.9760999896911051, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(529461, 'HP:0040332', 'Multifocal hypointensity of cerebral white matter on MRI', 'MP:0020141', 'decreased brain external capsule size', 0.4339622641509434, 10.963291078136551, 2.1812048548483416, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(529462, 'HP:0040332', 'Multifocal hypointensity of cerebral white matter on MRI', 'MP:0012461', 'increased brain internal capsule size', 0.42592592592592593, 10.963291078136551, 2.1609141361124817, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(529463, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0020144', 'small adrenal gland x-zone', 0.4444444444444444, 12.765845013930333, 2.3819548474058334, 'UPHENO:0003428', 'abnormal adrenal cortex'),
(529464, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0000642', 'enlarged adrenal glands', 0.5128205128205128, 12.732678149995134, 2.5553040011824506, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(529465, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0011362', 'ectopic adrenal gland', 0.425, 11.397693902282326, 2.2009134259370557, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(529466, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0013310', 'abnormal adrenal gland development', 0.4444444444444444, 11.397693902282326, 2.2506980549037894, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(529467, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0005355', 'enlarged thyroid gland', 0.4146341463414634, 7.914822368502075, 1.8115616512302797, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(529468, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0008291', 'abnormal adrenocortical cell morphology', 0.46511627906976744, 12.765845013930333, 2.436719584207551, 'UPHENO:0003428', 'abnormal adrenal cortex'),
(529469, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0008303', 'early degeneration of the adrenal gland x-zone', 0.4358974358974359, 12.765845013930333, 2.3589402511798174, 'UPHENO:0003428', 'abnormal adrenal cortex'),
(529470, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0002951', 'small thyroid gland', 0.4146341463414634, 7.914822368502075, 1.8115616512302797, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(529471, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0008301', 'adrenal medulla hyperplasia', 0.4318181818181818, 11.397693902282326, 2.218497567680373, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(529472, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0020143', 'abnormal adrenal gland x-zone size', 0.4878048780487805, 12.765845013930333, 2.4954441428751553, 'UPHENO:0003428', 'abnormal adrenal cortex'),
(529473, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0008302', 'thin adrenal cortex', 0.46511627906976744, 12.765845013930333, 2.436719584207551, 'UPHENO:0003428', 'abnormal adrenal cortex'),
(529474, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0009078', 'adrenal gland hyperplasia', 0.47619047619047616, 12.732678149995134, 2.46235254815923, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(529475, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0000640', 'adrenal gland hypoplasia', 0.45454545454545453, 12.732678149995134, 2.4057391748214343, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(529476, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0002768', 'small adrenal glands', 0.5128205128205128, 12.732678149995134, 2.5553040011824506, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(529477, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0013366', 'adrenal gland atrophy', 0.47619047619047616, 12.732678149995134, 2.46235254815923, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(529478, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0013308', 'decreased adrenal gland weight', 0.40476190476190477, 11.397693902282326, 2.147871572925379, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(529479, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0013560', 'abnormal endocrine gland morphology', 0.42424242424242425, 7.914822368502075, 1.8324310161808237, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(529480, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0008295', 'abnormal adrenal gland zona reticularis morphology', 0.4473684210526316, 12.765845013930333, 2.3897773802772138, 'UPHENO:0003428', 'abnormal adrenal cortex'),
(529481, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0013565', 'abnormal adrenal gland capsule morphology', 0.4444444444444444, 11.397693902282326, 2.2506980549037894, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(529482, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0008294', 'abnormal adrenal gland zona fasciculata morphology', 0.4473684210526316, 12.765845013930333, 2.3897773802772138, 'UPHENO:0003428', 'abnormal adrenal cortex'),
(529483, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0013307', 'increased adrenal gland weight', 0.425, 11.397693902282326, 2.2009134259370557, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(529484, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0020145', 'enlarged adrenal gland x-zone', 0.4444444444444444, 12.765845013930333, 2.3819548474058334, 'UPHENO:0003428', 'abnormal adrenal cortex'),
(529485, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0012689', 'abnormal adrenal gland weight', 0.4594594594594595, 11.397693902282326, 2.2884008126696282, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(529486, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0008300', 'enlarged adrenal medulla', 0.4634146341463415, 11.397693902282326, 2.2982293510087612, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(529487, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0008299', 'adrenal cortical hyperplasia', 0.47619047619047616, 12.765845013930333, 2.4655575061550077, 'UPHENO:0003428', 'abnormal adrenal cortex'),
(529488, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0008296', 'abnormal adrenal gland x-zone morphology', 0.4473684210526316, 12.765845013930333, 2.3897773802772138, 'UPHENO:0003428', 'abnormal adrenal cortex'),
(529489, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0011921', 'abnormal adrenal gland zona intermedia morphology', 0.4473684210526316, 12.765845013930333, 2.3897773802772138, 'UPHENO:0003428', 'abnormal adrenal cortex'),
(529490, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0008288', 'abnormal adrenal cortex morphology', 0.4722222222222222, 12.765845013930333, 2.455262857826562, 'UPHENO:0003428', 'abnormal adrenal cortex'),
(529491, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0000639', 'abnormal adrenal gland morphology', 0.47058823529411764, 11.397693902282326, 2.315949191993979, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(529492, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0008293', 'abnormal adrenal gland zona glomerulosa morphology', 0.4473684210526316, 12.765845013930333, 2.3897773802772138, 'UPHENO:0003428', 'abnormal adrenal cortex'),
(529493, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0008289', 'abnormal adrenal medulla morphology', 0.4444444444444444, 11.397693902282326, 2.2506980549037894, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(529494, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0003113', 'small parathyroid gland', 0.4146341463414634, 7.914822368502075, 1.8115616512302797, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(529495, 'HP:0001580', 'Pigmented micronodular adrenocortical disease', 'MP:0003112', 'enlarged parathyroid gland', 0.4146341463414634, 7.914822368502075, 1.8115616512302797, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(529496, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0000920', 'abnormal myelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529497, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529498, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0021010', 'impaired synaptic physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529499, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529500, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003469', 'decreased single cell response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529501, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0002064', 'seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529502, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0008840', 'abnormal spike wave discharge', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529503, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529504, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529505, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0005403', 'abnormal nerve conduction', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529506, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0004859', 'abnormal synaptic plasticity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529507, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529508, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529509, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003889', 'enhanced sensorimotor gating', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529510, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0004513', 'avnosmia', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529511, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529512, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529513, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0011397', 'endoneurial edema', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529514, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529515, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0000921', 'demyelination', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529516, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003633', 'abnormal nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529517, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529518, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529519, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003476', 'decreased summary potential intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529520, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529521, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529522, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0002826', 'tonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529523, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529524, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0000948', 'nonconvulsive seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529525, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529526, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003467', 'abnormal single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529527, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529528, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529529, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529530, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529531, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529532, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003463', 'abnormal single cell response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529533, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529534, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0011994', 'increased nerve conduction velocity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529535, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529536, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529537, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003472', 'increased summary potential threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529538, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529539, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529540, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0006080', 'brain ischemia', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529541, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529542, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003475', 'increased summary potential intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529543, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003216', 'absence seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529544, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003473', 'decreased summary potential threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529545, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529546, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529547, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529548, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003484', 'abnormal channel response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529549, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0014120', 'focal seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529550, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003474', 'abnormal summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529551, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003880', 'abnormal central pattern generator function', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529552, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0013806', 'encephalopathy', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529553, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529554, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529555, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529556, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0021015', 'increased tau protein phosphorylation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529557, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529558, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0002578', 'impaired ability to fire action potentials', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529559, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0000951', 'sporadic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529560, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0005402', 'abnormal action potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529561, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003466', 'decreased single cell response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529562, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529563, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0002635', 'reduced sensorimotor gating', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529564, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003464', 'abnormal single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529565, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529566, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0004811', 'abnormal neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529567, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003471', 'abnormal summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529568, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0006058', 'decreased cerebral infarct size', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529569, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003477', 'abnormal nerve fiber response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529570, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0021009', 'abnormal synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529571, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529572, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0002195', 'psychomotor seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529573, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529574, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529575, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003635', 'abnormal synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529576, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0004994', 'abnormal brain wave pattern', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529577, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529578, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529579, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003997', 'tonic-clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529580, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529581, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529582, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003996', 'clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529583, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529584, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0013438', 'dysmyelination', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529585, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529586, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0006060', 'increased cerebral infarct size', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529587, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0002634', 'abnormal sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529588, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0012006', 'abnormal hippocampus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529589, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0000947', 'convulsive seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529590, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0008814', 'decreased nerve conduction velocity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529591, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529592, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529593, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529594, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003480', 'increased nerve fiber response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529595, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003468', 'increased single cell response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529596, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003470', 'abnormal summary potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529597, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529598, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003482', 'increased nerve fiber response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529599, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0009358', 'environmentally induced seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529600, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0001499', 'abnormal kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529601, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529602, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0010050', 'hypermyelination', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529603, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529604, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0012011', 'febrile seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529605, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529606, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0005645', 'abnormal hypothalamus physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529607, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0002193', 'minimal clonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529608, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529609, 'HP:0032759', 'Focal sensory seizure with vestibular features', 'MP:0003465', 'increased single cell response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529610, 'HP:0002617', 'Vascular dilatation', 'MP:0020328', 'abnormal capillary density', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529611, 'HP:0002617', 'Vascular dilatation', 'MP:0000260', 'abnormal angiogenesis', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529612, 'HP:0002617', 'Vascular dilatation', 'MP:0005413', 'vascular restenosis', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529613, 'HP:0002617', 'Vascular dilatation', 'MP:0003658', 'abnormal capillary morphology', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529614, 'HP:0002617', 'Vascular dilatation', 'MP:0005340', 'abnormal susceptibility to atherosclerosis', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529615, 'HP:0002617', 'Vascular dilatation', 'MP:0006083', 'abnormal blood vessel elastic tissue morphology', 0.45161290322580644, 6.6481113184978895, 1.7327356559830975, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529616, 'HP:0002617', 'Vascular dilatation', 'MP:0005338', 'atherosclerotic lesions', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529617, 'HP:0002617', 'Vascular dilatation', 'MP:0013812', 'enlarged orbital veins', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529618, 'HP:0002617', 'Vascular dilatation', 'MP:0010017', 'visceral vascular congestion', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529619, 'HP:0002617', 'Vascular dilatation', 'MP:0013811', 'abnormal orbital vein morphology', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529620, 'HP:0002617', 'Vascular dilatation', 'MP:0000265', 'blood vessel atresia', 0.4117647058823529, 6.6481113184978895, 1.6545263980167935, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529621, 'HP:0002617', 'Vascular dilatation', 'MP:0011569', 'abnormal azygos vein morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529622, 'HP:0002617', 'Vascular dilatation', 'MP:0020330', 'increased capillary density', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529623, 'HP:0002617', 'Vascular dilatation', 'MP:0001614', 'abnormal blood vessel morphology', 0.4642857142857143, 6.6481113184978895, 1.756878798369351, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529624, 'HP:0002617', 'Vascular dilatation', 'MP:0004125', 'abnormal venule morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529625, 'HP:0002617', 'Vascular dilatation', 'MP:0009577', 'abnormal developmental vascular remodeling', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529626, 'HP:0002617', 'Vascular dilatation', 'MP:0013925', 'abnormal vascular plexus formation', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529627, 'HP:0002617', 'Vascular dilatation', 'MP:0013863', 'abnormal paraumbilical vein morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529628, 'HP:0002617', 'Vascular dilatation', 'MP:0001619', 'abnormal vascular permeability', 0.40540540540540543, 7.347404004220494, 1.7258844975861822, 'UPHENO:0080362', 'abnormal cardiovascular system'),
(529629, 'HP:0002617', 'Vascular dilatation', 'MP:0020373', 'abnormal blood vessel lumen formation', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529630, 'HP:0002617', 'Vascular dilatation', 'MP:0002191', 'abnormal artery morphology', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529631, 'HP:0002617', 'Vascular dilatation', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(529632, 'HP:0002617', 'Vascular dilatation', 'MP:0003227', 'abnormal vascular branching morphogenesis', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529633, 'HP:0002617', 'Vascular dilatation', 'MP:0013869', 'vascular diverticulum', 0.4482758620689655, 6.6481113184978895, 1.7263220535085824, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529634, 'HP:0002617', 'Vascular dilatation', 'MP:0003991', 'arteriosclerosis', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529635, 'HP:0002617', 'Vascular dilatation', 'MP:0005601', 'increased angiogenesis', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529636, 'HP:0002617', 'Vascular dilatation', 'MP:0004112', 'abnormal arteriole morphology', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529637, 'HP:0002617', 'Vascular dilatation', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(529638, 'HP:0002617', 'Vascular dilatation', 'MP:0005412', 'vascular stenosis', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529639, 'HP:0002617', 'Vascular dilatation', 'MP:0013872', 'abnormal jugular vein morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529640, 'HP:0002617', 'Vascular dilatation', 'MP:0020329', 'decreased capillary density', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529641, 'HP:0002617', 'Vascular dilatation', 'MP:0003710', 'abnormal physiological neovascularization', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529642, 'HP:0002617', 'Vascular dilatation', 'MP:0006136', 'varicose veins', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529643, 'HP:0002617', 'Vascular dilatation', 'MP:0005602', 'decreased angiogenesis', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529644, 'HP:0002617', 'Vascular dilatation', 'MP:0011655', 'abnormal systemic artery morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529645, 'HP:0002617', 'Vascular dilatation', 'MP:0002725', 'abnormal vein morphology', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529646, 'HP:0002617', 'Vascular dilatation', 'MP:0013983', 'abnormal superior mesenteric vein morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529647, 'HP:0002617', 'Vascular dilatation', 'MP:0000255', 'blood vessel congestion', 0.4482758620689655, 6.6481113184978895, 1.7263220535085824, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529648, 'HP:0002617', 'Vascular dilatation', 'MP:0013332', 'peliosis', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(529649, 'HP:0002617', 'Vascular dilatation', 'MP:0000486', 'abnormal pulmonary trunk morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529650, 'HP:0002617', 'Vascular dilatation', 'MP:0012562', 'blood vessel degeneration', 0.4117647058823529, 6.6481113184978895, 1.6545263980167935, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529651, 'HP:0002617', 'Vascular dilatation', 'MP:0010668', 'abnormal hepatic portal vein morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529652, 'HP:0002617', 'Vascular dilatation', 'MP:0003228', 'abnormal sinus venosus morphology', 0.40625, 5.978701727774094, 1.5584760430973028, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(529653, 'HP:0002617', 'Vascular dilatation', 'MP:0009489', 'abnormal blood vessel endothelium morphology', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529654, 'HP:0002617', 'Vascular dilatation', 'MP:0000259', 'abnormal vascular development', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529655, 'HP:0002617', 'Vascular dilatation', 'MP:0012253', 'abnormal intersomitic vessel morphology', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529656, 'HP:0002617', 'Vascular dilatation', 'MP:0002925', 'abnormal cardiovascular development', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(529657, 'HP:0002617', 'Vascular dilatation', 'MP:0014264', 'abnormal perivascular vein cell coverage', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529658, 'HP:0002617', 'Vascular dilatation', 'MP:0003279', 'aneurysm', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(529659, 'HP:0002617', 'Vascular dilatation', 'MP:0005341', 'decreased susceptibility to atherosclerosis', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(529660, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0000432', 'abnormal head morphology', 0.42424242424242425, 4.6730878730104815, 1.4080206418742023, 'UPHENO:0087907', 'abnormal head morphology'),
(529661, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0030227', 'abnormal tubotympanic recess morphology', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(529662, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0000026', 'abnormal inner ear morphology', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(529663, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0000049', 'abnormal middle ear morphology', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(529664, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0003938', 'abnormal ear development', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(529665, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0013102', 'ear open puncture', 0.40476190476190477, 9.987538624383228, 2.010615616543463, 'UPHENO:0002901', 'abnormal external ear'),
(529666, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0013098', 'ear open abrasion', 0.40476190476190477, 9.987538624383228, 2.010615616543463, 'UPHENO:0002901', 'abnormal external ear'),
(529667, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0013097', 'ear wound', 0.425, 9.987538624383228, 2.060267923199037, 'UPHENO:0002901', 'abnormal external ear'),
(529668, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0002177', 'abnormal outer ear morphology', 0.4594594594594595, 9.987538624383228, 2.1421645823067825, 'UPHENO:0002901', 'abnormal external ear'),
(529669, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0030092', 'abnormal outer ear helix morphology', 0.4358974358974359, 9.987538624383228, 2.086514432563373, 'UPHENO:0002901', 'abnormal external ear'),
(529670, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0003737', 'ossification of pinnae', 0.4473684210526316, 9.987538624383228, 2.1137902886976505, 'UPHENO:0002901', 'abnormal external ear'),
(529671, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0000023', 'abnormal ear position', 0.40476190476190477, 9.987538624383228, 2.010615616543463, 'UPHENO:0002901', 'abnormal external ear'),
(529672, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0003682', 'linear crease in ear lobe', 0.425, 9.987538624383228, 2.060267923199037, 'UPHENO:0002901', 'abnormal external ear'),
(529673, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0002102', 'abnormal ear morphology', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(529674, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0003677', 'abnormal ear lobe morphology', 0.4358974358974359, 9.987538624383228, 2.086514432563373, 'UPHENO:0002901', 'abnormal external ear'),
(529675, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0030226', 'middle ear polyps', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(529676, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0030160', 'abnormal auditory bulla morphology', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(529677, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0030161', 'absent auditory bulla', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(529678, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0020290', 'floppy ears', 0.4473684210526316, 9.987538624383228, 2.1137902886976505, 'UPHENO:0002901', 'abnormal external ear'),
(529679, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0013099', 'ear open avulsion', 0.40476190476190477, 9.987538624383228, 2.010615616543463, 'UPHENO:0002901', 'abnormal external ear'),
(529680, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0013101', 'ear open laceration', 0.40476190476190477, 9.987538624383228, 2.010615616543463, 'UPHENO:0002901', 'abnormal external ear'),
(529681, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0012176', 'abnormal head development', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(529682, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0000020', 'scaly ears', 0.4473684210526316, 9.987538624383228, 2.1137902886976505, 'UPHENO:0002901', 'abnormal external ear'),
(529683, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0006033', 'abnormal external auditory canal morphology', 0.425, 9.987538624383228, 2.060267923199037, 'UPHENO:0002901', 'abnormal external ear'),
(529684, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0013103', 'ear closed contusion', 0.40476190476190477, 9.987538624383228, 2.010615616543463, 'UPHENO:0002901', 'abnormal external ear'),
(529685, 'HP:0040095', 'Neoplasm of the outer ear', 'MP:0013100', 'ear open incision', 0.40476190476190477, 9.987538624383228, 2.010615616543463, 'UPHENO:0002901', 'abnormal external ear'),
(529686, 'HP:0003572', 'Low plasma citrulline', 'MP:0020835', 'abnormal circulating citrulline level', 0.40540540540540543, 15.022184767190119, 2.4678077124479567, 'UPHENO:0051789', 'abnormal blood citrulline level'),
(529687, 'HP:0003572', 'Low plasma citrulline', 'MP:0020837', 'decreased circulating citrulline level', 0.4810126582278481, 16.607147267911277, 2.826348890869517, 'UPHENO:0034331', 'decreased level of citrulline in blood'),
(529688, 'HP:0003572', 'Low plasma citrulline', 'MP:0012334', 'decreased circulating homocysteine level', 0.40476190476190477, 11.700256672302759, 2.176193506305092, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(529689, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0006188', 'calcified retina', 0.4166666666666667, 9.356059413574362, 1.9744260150710429, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(529690, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0006249', 'phthisis bulbi', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529691, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0005195', 'abnormal posterior eye segment morphology', 0.425531914893617, 7.832360208310102, 1.82562845003543, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(529692, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0003381', 'vitreal fibroplasia', 0.4117647058823529, 7.832360208310102, 1.7958534176094256, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(529693, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0001289', 'persistence of hyaloid vascular system', 0.40384615384615385, 7.832360208310102, 1.7785017699354968, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(529694, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0006209', 'calcified intraocular region', 0.4489795918367347, 8.581084971325078, 1.962837748756089, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529695, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0006164', 'ectropion', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(529696, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0014087', 'retrolental blood', 0.4166666666666667, 7.832360208310102, 1.806511394962459, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(529697, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0031290', 'bilateral microphthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529698, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0006186', 'retina fibrosis', 0.42105263157894735, 9.356059413574362, 1.9847905273087305, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(529699, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0006200', 'vitreous body deposition', 0.4117647058823529, 7.832360208310102, 1.7958534176094256, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(529700, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0006248', 'lagophthalmos', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529701, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0002699', 'abnormal vitreous body morphology', 0.42, 7.832360208310102, 1.8137230459720808, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(529702, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0009274', 'buphthalmos', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529703, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0003099', 'retina detachment', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(529704, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0006225', 'ocular rupture', 0.4489795918367347, 8.581084971325078, 1.962837748756089, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529705, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0001326', 'retina degeneration', 0.41379310344827586, 9.356059413574362, 1.9676058702873884, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(529706, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0005176', 'eyelids fail to open', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529707, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0010081', 'posterior microphthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529708, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0001296', 'macrophthalmia', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529709, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0002864', 'abnormal ocular fundus morphology', 0.4375, 9.356059413574362, 2.023184616746278, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(529710, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0002697', 'abnormal eye size', 0.4489795918367347, 8.581084971325078, 1.962837748756089, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529711, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0031289', 'unilateral microphthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529712, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0001297', 'microphthalmia', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529713, 'HP:0025583', 'Tapetal-like fundal reflex', 'MP:0003671', 'abnormal eyelid aperture', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(529714, 'HP:0005682', 'Talocalcaneal synostosis', 'MP:0008919', 'fused tarsal bones', 0.4148936170212766, 15.192109768632433, 2.5105994049414133, 'UPHENO:0078155', 'abnormally fused tarsal bone and tarsal bone'),
(529715, 'HP:0030608', 'Increased OCT-measured macular thickness', 'MP:0001296', 'macrophthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529716, 'HP:0030608', 'Increased OCT-measured macular thickness', 'MP:0002697', 'abnormal eye size', 0.44, 8.581084971325078, 1.9431102355201144, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529717, 'HP:0030608', 'Increased OCT-measured macular thickness', 'MP:0002699', 'abnormal vitreous body morphology', 0.4117647058823529, 7.832360208310102, 1.7958534176094256, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(529718, 'HP:0030608', 'Increased OCT-measured macular thickness', 'MP:0003381', 'vitreal fibroplasia', 0.40384615384615385, 7.832360208310102, 1.7785017699354968, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(529719, 'HP:0030608', 'Increased OCT-measured macular thickness', 'MP:0005176', 'eyelids fail to open', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529720, 'HP:0030608', 'Increased OCT-measured macular thickness', 'MP:0014087', 'retrolental blood', 0.40816326530612246, 7.832360208310102, 1.7879825831583462, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(529721, 'HP:0030608', 'Increased OCT-measured macular thickness', 'MP:0006209', 'calcified intraocular region', 0.44, 8.581084971325078, 1.9431102355201144, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529722, 'HP:0030608', 'Increased OCT-measured macular thickness', 'MP:0006225', 'ocular rupture', 0.44, 8.581084971325078, 1.9431102355201144, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529723, 'HP:0030608', 'Increased OCT-measured macular thickness', 'MP:0005195', 'abnormal posterior eye segment morphology', 0.4166666666666667, 7.832360208310102, 1.806511394962459, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(529724, 'HP:0030608', 'Increased OCT-measured macular thickness', 'MP:0006200', 'vitreous body deposition', 0.40384615384615385, 7.832360208310102, 1.7785017699354968, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(529725, 'HP:0030608', 'Increased OCT-measured macular thickness', 'MP:0001297', 'microphthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(529726, 'HP:0010811', 'Narrow uvula', 'MP:0003758', 'narrow palate', 0.4626865671641791, 11.136827333131242, 2.26999127924904, 'UPHENO:0076760', 'abnormal secondary palate morphology'),
(529727, 'HP:0010811', 'Narrow uvula', 'MP:0031505', 'decreased mouth width', 0.4117647058823529, 10.692263881549227, 2.0982604443687687, 'UPHENO:0034770', 'decreased width of the anatomical entity in independent continuant'),
(529728, 'HP:0010811', 'Narrow uvula', 'MP:0030291', 'short soft palate', 0.43661971830985913, 13.437222266468964, 2.42218005128699, 'UPHENO:0021823', 'abnormal soft palate morphology'),
(529729, 'HP:0010811', 'Narrow uvula', 'MP:0003760', 'decreased palatal length', 0.4027777777777778, 11.136827333131242, 2.117939225930106, 'UPHENO:0076760', 'abnormal secondary palate morphology'),
(529730, 'HP:0032147', 'Erythromelalgia', 'MP:0005499', 'abnormal olfactory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529731, 'HP:0032147', 'Erythromelalgia', 'MP:0014134', 'abnormal embryo morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529732, 'HP:0032147', 'Erythromelalgia', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529733, 'HP:0032147', 'Erythromelalgia', 'MP:0011989', 'abnormal porphyrin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529734, 'HP:0032147', 'Erythromelalgia', 'MP:0011479', 'abnormal catecholamine level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529735, 'HP:0032147', 'Erythromelalgia', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529736, 'HP:0032147', 'Erythromelalgia', 'MP:0003385', 'abnormal body wall morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529737, 'HP:0032147', 'Erythromelalgia', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529738, 'HP:0032147', 'Erythromelalgia', 'MP:0002163', 'abnormal gland morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529739, 'HP:0032147', 'Erythromelalgia', 'MP:0005332', 'abnormal amino acid level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529740, 'HP:0032147', 'Erythromelalgia', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529741, 'HP:0032147', 'Erythromelalgia', 'MP:0002111', 'abnormal tail morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529742, 'HP:0032147', 'Erythromelalgia', 'MP:0008469', 'abnormal protein level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529743, 'HP:0032147', 'Erythromelalgia', 'MP:0000001', 'mammalian phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(529744, 'HP:0032147', 'Erythromelalgia', 'MP:0021122', 'abnormal trimethylamine N-oxide level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529745, 'HP:0032147', 'Erythromelalgia', 'MP:0021145', 'abnormal amino acid derivative level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529746, 'HP:0032147', 'Erythromelalgia', 'MP:0011475', 'abnormal glycosaminoglycan level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529747, 'HP:0032147', 'Erythromelalgia', 'MP:0005500', 'abnormal gustatory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(529748, 'HP:0012033', 'Sacral lipoma', 'MP:0020130', 'abnormal total fat pad weight', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529749, 'HP:0012033', 'Sacral lipoma', 'MP:0002970', 'abnormal white adipose tissue morphology', 0.42857142857142855, 10.226325483970346, 2.0934925177085244, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529750, 'HP:0012033', 'Sacral lipoma', 'MP:0011167', 'abnormal adipose tissue development', 0.4444444444444444, 10.226325483970346, 2.1319084287162204, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529751, 'HP:0012033', 'Sacral lipoma', 'MP:0013801', 'abnormal subscapular fat pad morphology', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529752, 'HP:0012033', 'Sacral lipoma', 'MP:0000003', 'abnormal adipose tissue morphology', 0.46153846153846156, 10.226325483970346, 2.172519857461201, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529753, 'HP:0012033', 'Sacral lipoma', 'MP:0005458', 'increased percent body fat/body weight', 0.42857142857142855, 10.226325483970346, 2.0934925177085244, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529754, 'HP:0012033', 'Sacral lipoma', 'MP:0020520', 'whitened brown adipose tissue morphology', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529755, 'HP:0012033', 'Sacral lipoma', 'MP:0012320', 'abnormal body fat mass', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529756, 'HP:0012033', 'Sacral lipoma', 'MP:0005457', 'abnormal percent body fat/body weight', 0.4444444444444444, 10.226325483970346, 2.1319084287162204, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529757, 'HP:0012033', 'Sacral lipoma', 'MP:0002971', 'abnormal brown adipose tissue morphology', 0.42857142857142855, 10.226325483970346, 2.0934925177085244, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529758, 'HP:0012033', 'Sacral lipoma', 'MP:0005459', 'decreased percent body fat/body weight', 0.42857142857142855, 10.226325483970346, 2.0934925177085244, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529759, 'HP:0012033', 'Sacral lipoma', 'MP:0013800', 'abnormal pericardial fat pad morphology', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529760, 'HP:0012033', 'Sacral lipoma', 'MP:0011174', 'lipodystrophy', 0.4444444444444444, 10.226325483970346, 2.1319084287162204, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529761, 'HP:0012033', 'Sacral lipoma', 'MP:0005334', 'abnormal fat pad morphology', 0.42857142857142855, 10.226325483970346, 2.0934925177085244, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529762, 'HP:0012033', 'Sacral lipoma', 'MP:0020521', 'browned white adipose tissue morphology', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(529763, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529764, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0003467', 'abnormal single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529765, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529766, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529767, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0003880', 'abnormal central pattern generator function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529768, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529769, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529770, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529771, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529772, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0021015', 'increased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529773, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0003464', 'abnormal single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529774, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0002635', 'reduced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529775, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0003463', 'abnormal single cell response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529776, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0005402', 'abnormal action potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529777, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529778, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529779, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0008814', 'decreased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529780, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529781, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0003470', 'abnormal summary potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529782, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529783, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0003477', 'abnormal nerve fiber response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529784, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529785, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0002634', 'abnormal sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529786, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0003633', 'abnormal nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529787, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0004994', 'abnormal brain wave pattern', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529788, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529789, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529790, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529791, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529792, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529793, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529794, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0003471', 'abnormal summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529795, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529796, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0013806', 'encephalopathy', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529797, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0003889', 'enhanced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529798, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0003474', 'abnormal summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529799, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0012006', 'abnormal hippocampus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529800, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0002064', 'seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529801, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529802, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0006080', 'brain ischemia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529803, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0002578', 'impaired ability to fire action potentials', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529804, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0005403', 'abnormal nerve conduction', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529805, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0011994', 'increased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529806, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529807, 'HP:0032937', 'Recurrent, involuntary and intrusive distressing memories', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(529808, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529809, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529810, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529811, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003665', 'endophthalmitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529812, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529813, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003566', 'abnormal cell adhesion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529814, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012556', 'increased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529815, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000423', 'delayed hair regrowth', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529816, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529817, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010539', 'decreased level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529818, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010393', 'shortened QRS complex duration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529819, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005036', 'diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529820, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529821, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002106', 'abnormal muscle physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529822, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012610', 'increased complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529823, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529824, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008942', 'abnormal induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529825, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010505', 'abnormal T wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529826, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008679', 'decreased interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529827, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012554', 'increased serum complement activity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529828, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529829, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008563', 'decreased interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529830, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003899', 'abnormal QT interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529831, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010211', 'abnormal acute phase protein level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529832, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529833, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529834, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006114', 'cardiac murmur', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529835, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013145', 'eye discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529836, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010992', 'increased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529837, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003875', 'abnormal hair follicle regression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529838, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014275', 'increased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529839, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010994', 'aerophagia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529840, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006265', 'increased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529841, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003787', 'abnormal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529842, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011043', 'abnormal lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529843, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529844, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008004', 'abnormal stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529845, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529846, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529847, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010758', 'increased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529848, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529849, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529850, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529851, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020137', 'decreased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529852, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012111', 'failure of morula compaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529853, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529854, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030940', 'impaired autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529855, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003901', 'abnormal PR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529856, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031013', 'abnormal egg activation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529857, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013208', 'abnormal cilium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529858, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529859, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030951', 'abnormal endocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529860, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008711', 'increased interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529861, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529862, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009344', 'abnormal ovulation cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529863, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003077', 'abnormal cell cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529864, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005666', 'abnormal adipose tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529865, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011953', 'prolonged PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529866, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011994', 'increased nerve conduction velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529867, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003011', 'delayed dark adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529868, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031241', 'decreased CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529869, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000343', 'abnormal response to cardiac infarction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529870, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031086', 'wheezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529871, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529872, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020154', 'impaired humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529873, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003897', 'abnormal ST segment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529874, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001876', 'decreased inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529875, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529876, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529877, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529878, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001873', 'stomach inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529879, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529880, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011164', 'panniculitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529881, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013135', 'poor circulation in tail', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529882, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014046', 'abnormal mitophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529883, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529884, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529885, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529886, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020080', 'increased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529887, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000350', 'abnormal cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529888, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004781', 'abnormal surfactant composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529889, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030129', 'tongue inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529890, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529891, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000304', 'abnormal cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529892, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529893, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011954', 'shortened PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529894, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003482', 'increased nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529895, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008675', 'increased interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529896, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002164', 'abnormal gland physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529897, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529898, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529899, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008676', 'decreased interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529900, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529901, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008566', 'increased interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529902, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003394', 'increased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529903, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006046', 'atrioventricular valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529904, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013642', 'decreased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529905, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529906, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001857', 'pericarditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529907, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012382', 'abnormal blood cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529908, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529909, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000352', 'decreased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529910, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010634', 'increased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529911, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005333', 'decreased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529912, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529913, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529914, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005620', 'abnormal muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529915, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529916, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010957', 'abnormal aerobic respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529917, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529918, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020414', 'abnormal fibroblast physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529919, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011418', 'leukocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529920, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030153', 'dental pulp inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529921, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003473', 'decreased summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529922, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031226', 'increased CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529923, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529924, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012006', 'abnormal hippocampus physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529925, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003261', 'hematemesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529926, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001912', 'increased cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529927, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529928, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010559', 'heart block', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529929, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529930, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010143', 'enhanced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529931, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529932, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010896', 'decreased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529933, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009275', 'bruising', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529934, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001854', 'atrial endocarditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529935, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010954', 'abnormal cellular respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529936, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529937, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529938, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005085', 'abnormal gallbladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529939, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529940, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529941, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001627', 'abnormal cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529942, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001790', 'abnormal immune system physiology', 0.6086956521739131, 7.400946880077414, 2.122480668433333, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529943, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529944, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529945, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003882', 'abnormal pulse pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529946, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002626', 'increased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529947, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001756', 'abnormal urination', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529948, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003039', 'increased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529949, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529950, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002420', 'abnormal adaptive immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529951, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529952, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010750', 'increased susceptibility to parasitic infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529953, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003091', 'abnormal cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529954, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529955, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529956, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529957, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031098', 'abnormal sputum production', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529958, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031224', 'abnormal CXCL10 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529959, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003306', 'small intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529960, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008539', 'decreased susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529961, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031051', 'lymph node hemorrhage', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529962, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030990', 'nerve inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529963, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529964, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000316', 'cellular necrosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529965, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529966, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020097', 'low mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529967, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529968, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008817', 'hematoma', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529969, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003481', 'decreased nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529970, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529971, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013971', 'blood in lymph vessels', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529972, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005037', 'mucous diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529973, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008687', 'increased interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529974, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529975, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002333', 'abnormal lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529976, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004031', 'insulitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529977, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001598', 'abnormal blood viscosity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529978, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002498', 'abnormal acute inflammation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529979, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012685', 'abnormal primitive streak elongation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529980, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529981, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529982, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005671', 'abnormal response to transplant', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529983, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003824', 'decreased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529984, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000740', 'impaired smooth muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529985, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010756', 'decreased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529986, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030214', 'muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529987, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529988, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009792', 'seborrheic dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529989, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006082', 'CNS inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529990, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031402', 'decreased muscle fatigability', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529991, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008669', 'increased interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529992, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003251', 'gallbladder inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529993, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529994, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010570', 'prolonged ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529995, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005000', 'abnormal immune tolerance', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529996, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008703', 'decreased interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529997, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(529998, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003475', 'increased summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(529999, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004742', 'abnormal vestibular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530000, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009567', 'mitotic nondisjunction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530001, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530002, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000738', 'impaired muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530003, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002314', 'abnormal respiratory mechanics', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530004, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010751', 'decreased susceptibility to parasitic infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530005, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001984', 'abnormal olfaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530006, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011925', 'abnormal heart echocardiography feature', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530007, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008663', 'increased interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530008, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530009, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008721', 'abnormal chemokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530010, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002934', 'acute joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530011, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031248', 'increased CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530012, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008008', 'early cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530013, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013636', 'abnormal bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530014, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002296', 'aspiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530015, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001954', 'respiratory distress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530016, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030822', 'sacroiliac joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530017, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020001', 'decreased response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530018, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004070', 'abnormal P wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530019, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003254', 'bile duct inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530020, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011937', 'shortened PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530021, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031095', 'pharyngitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530022, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001761', 'abnormal urination pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530023, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002406', 'increased susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530024, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020002', 'increased response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530025, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530026, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530027, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003926', 'decreased cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530028, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004037', 'increased muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530029, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530030, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010752', 'impaired mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530031, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003741', 'tinnitus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530032, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014132', 'abnormal tear film physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530033, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010028', 'aciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530034, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008684', 'increased interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530035, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008705', 'increased interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530036, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004879', 'decreased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530037, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005190', 'osteomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530038, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001950', 'abnormal respiratory sounds', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530039, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031014', 'polyspermy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530040, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004877', 'abnormal systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530041, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004046', 'abnormal mitosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530042, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008708', 'increased interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530043, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530044, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031055', 'bronchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530045, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530046, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530047, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012120', 'trophectoderm cell degeneration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530048, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030941', 'enhanced autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530049, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002933', 'joint inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530050, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530051, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009057', 'increased interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530052, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012201', 'decreased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530053, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003476', 'decreased summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530054, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030118', 'rhinosinusitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530055, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530056, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530057, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001924', 'infertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530058, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530059, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008744', 'abnormal B cell anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530060, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030987', 'spinal cord inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530061, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005575', 'increased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530062, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001664', 'abnormal digestion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530063, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530064, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031066', 'cytokine storm', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530065, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530066, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003880', 'abnormal central pattern generator function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530067, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012609', 'decreased complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530068, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008555', 'abnormal interferon secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530069, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530070, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530071, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030939', 'abnormal autophagosome formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530072, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530073, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004945', 'abnormal bone resorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530074, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005551', 'abnormal eye electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530075, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530076, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008747', 'abnormal T cell anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530077, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530078, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011431', 'increased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530079, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001845', 'abnormal inflammatory response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530080, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004994', 'abnormal brain wave pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530081, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002128', 'abnormal blood circulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530082, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530083, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011804', 'increased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530084, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530085, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001864', 'vascular inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530086, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009046', 'muscle twitch', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530087, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003480', 'increased nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530088, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031225', 'decreased CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530089, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001951', 'abnormal breathing pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530090, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530091, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009790', 'decreased susceptibility to viral infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530092, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009348', 'abnormal urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530093, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008661', 'decreased interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530094, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004211', 'abnormal sour taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530095, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530096, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530097, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002090', 'abnormal vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530098, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010519', 'atrioventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530099, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031246', 'abnormal CCL3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530100, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005410', 'abnormal fertilization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530101, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013498', 'trachea inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530102, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020142', 'increased anti-sperm antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530103, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003699', 'abnormal female reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530104, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530105, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530106, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005621', 'abnormal cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530107, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530108, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004752', 'decreased length of allograft survival', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530109, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009384', 'cardiac valve regurgitation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530110, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530111, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003674', 'oxidative stress', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530112, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530113, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011952', 'decreased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530114, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011931', 'abnormal pulmonary valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530115, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011805', 'decreased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530116, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530117, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008003', 'achlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530118, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003292', 'melena', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530119, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530120, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031222', 'decreased CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530121, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031127', 'dry gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530122, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010513', 'abnormal ventricular activation time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530123, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530124, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530125, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530126, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020138', 'delayed bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530127, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530128, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008722', 'abnormal chemokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530129, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530130, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530131, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031092', 'dysgeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530132, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0021015', 'increased tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530133, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008009', 'delayed cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530134, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003122', 'maternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530135, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530136, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031170', 'abnormal vasculature physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530137, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001851', 'eye inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530138, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003698', 'abnormal male reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530139, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002993', 'arthritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530140, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031088', 'coughing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530141, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013559', 'abnormal exocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530142, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004510', 'myositis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530143, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010571', 'shortened ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530144, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013557', 'abnormal merocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530145, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008001', 'hypochlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530146, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003547', 'abnormal pulmonary pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530147, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005580', 'periinsulitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530148, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004072', 'abnormal frontal plane axis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530149, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012200', 'increased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530150, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009661', 'abnormal pregnancy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530151, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530152, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002334', 'abnormal airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530153, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530154, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530155, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003233', 'prolonged QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530156, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001986', 'abnormal taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530157, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001663', 'abnormal digestive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530158, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530159, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020846', 'abnormal cell motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530160, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530161, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008814', 'decreased nerve conduction velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530162, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031118', 'cardiovalvulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530163, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031009', 'abnormal sperm-egg fusion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530164, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530165, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001934', 'increased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530166, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530167, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005076', 'abnormal cell differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530168, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014274', 'decreased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530169, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003464', 'abnormal single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530170, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530171, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530172, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000948', 'nonconvulsive seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530173, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004010', 'increased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530174, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530175, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001872', 'sinus inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530176, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008776', 'increased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530177, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010381', 'abnormal dosage compensation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530178, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530179, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004149', 'increased bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530180, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011421', 'cylindruria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530181, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008750', 'abnormal interferon level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530182, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003465', 'increased single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530183, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030938', 'abnormal reticulophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530184, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530185, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000743', 'muscle spasm', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530186, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001337', 'dry eyes', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530187, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530188, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008699', 'increased interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530189, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530190, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006336', 'abnormal otoacoustic response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530191, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008943', 'increased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530192, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001841', 'decreased level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530193, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010515', 'abnormal Q wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530194, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002999', 'abnormal bone healing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530195, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530196, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530197, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530198, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003466', 'decreased single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530199, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004036', 'abnormal muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530200, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003823', 'increased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530201, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006049', 'semilunar valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530202, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008568', 'abnormal interleukin secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530203, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004512', 'anosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530204, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002330', 'abnormal bronchial provocation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530205, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013634', 'increased femur fracture load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530206, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008544', 'impaired olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530207, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530208, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001985', 'abnormal gustatory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530209, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008271', 'abnormal bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530210, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001800', 'abnormal humoral immune response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530211, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002472', 'impaired complement alternative pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530212, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009247', 'meteorism', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530213, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011763', 'urethritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530214, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003868', 'abnormal feces composition', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530215, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020218', 'abnormal tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530216, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031169', 'abnormal joint physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530217, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020412', 'abnormal amnion physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530218, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530219, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008673', 'decreased interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530220, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530221, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031091', 'hypogeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530222, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002418', 'increased susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530223, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530224, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530225, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530226, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013475', 'delayed reproductive senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530227, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020096', 'high mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530228, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011012', 'bronchiectasis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530229, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010560', 'intraventricular block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530230, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003298', 'choking', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530231, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011082', 'abnormal gastrointestinal motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530232, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011046', 'abnormal lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530233, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530234, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001840', 'increased level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530235, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530236, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005576', 'decreased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530237, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005004', 'abnormal lymphocyte anergy', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530238, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008775', 'abnormal heart ventricle pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530239, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031424', 'enhanced female fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530240, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003725', 'increased autoantibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530241, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030988', 'dysosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530242, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000951', 'sporadic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530243, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011762', 'renal/urinary system inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530244, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001850', 'increased susceptibility to otitis media', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530245, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530246, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013639', 'decreased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530247, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004558', 'delayed allantois development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530248, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001862', 'interstitial pneumonia', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530249, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009562', 'abnormal odor adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530250, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000313', 'abnormal cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530251, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006194', 'keratoconjunctivitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530252, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031126', 'gangrene', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530253, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010377', 'abnormal gut flora balance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530254, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530255, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003472', 'increased summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530256, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530257, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530258, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002064', 'seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530259, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002500', 'granulomatous inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530260, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010741', 'abnormal melanocyte proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530261, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003009', 'abnormal cytokine secretion', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530262, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530263, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013555', 'abnormal apocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530264, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001313', 'increased incidence of corneal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530265, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005253', 'abnormal eye physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530266, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011809', 'abnormal anoikis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530267, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020155', 'enhanced humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530268, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530269, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008706', 'decreased interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530270, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008712', 'decreased interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530271, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530272, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001919', 'abnormal reproductive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530273, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020039', 'increased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530274, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003186', 'abnormal redox activity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530275, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530276, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004005', 'impaired contractility of intestinal smooth muscle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530277, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530278, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530279, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003927', 'increased cellular glucose import', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530280, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530281, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530282, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530283, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002322', 'abnormal respiratory transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530284, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003260', 'vomiting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530285, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004212', 'abnormal salty taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530286, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003889', 'enhanced sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530287, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010637', 'sinus bradycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530288, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031102', 'rhinorrhea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530289, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008562', 'increased interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530290, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010071', 'abnormal pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530291, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003467', 'abnormal single cell response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530292, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010553', 'prolonged HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530293, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006002', 'abnormal small intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530294, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008652', 'decreased interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530295, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031129', 'left-to-right shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530296, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001819', 'abnormal immune cell physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530297, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008693', 'increased interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530298, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530299, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530300, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530301, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011920', 'abnormal S wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530302, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530303, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530304, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003898', 'abnormal QRS complex', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530305, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010950', 'abnormal lung hysteresivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530306, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031054', 'bronchiolitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530307, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002634', 'abnormal sensorimotor gating', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530308, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008670', 'decreased interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530309, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530310, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031469', 'abnormal pinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530311, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530312, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012553', 'decreased serum complement activity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530313, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010895', 'increased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530314, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008748', 'abnormal central T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530315, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008681', 'increased interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530316, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530317, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001752', 'abnormal hypothalamus secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530318, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000501', 'abnormal digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530319, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011929', 'abnormal aortic valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530320, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001666', 'abnormal intestinal absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530321, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530322, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031105', 'rhonchi', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530323, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030132', 'periodontium inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530324, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530325, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003878', 'abnormal ear physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530326, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002841', 'impaired skeletal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530327, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000427', 'abnormal hair cycle', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530328, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008688', 'decreased interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530329, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530330, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001921', 'reduced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530331, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009788', 'increased susceptibility to bacterial infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530332, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003928', 'increased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530333, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530334, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014120', 'focal seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530335, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006138', 'congestive heart failure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530336, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013627', 'increased vertebra yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530337, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030215', 'facial muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530338, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008696', 'increased interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530339, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530340, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001837', 'defective assembly of class I molecules', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530341, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003304', 'large intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530342, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008678', 'increased interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530343, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530344, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004760', 'increased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530345, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530346, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012555', 'decreased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530347, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003474', 'abnormal summary potential intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530348, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005402', 'abnormal action potential', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530349, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002405', 'respiratory system inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530350, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002578', 'impaired ability to fire action potentials', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530351, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004751', 'increased length of allograft survival', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530352, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530353, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001849', 'ear inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530354, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530355, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006001', 'abnormal intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530356, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530357, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001636', 'irregular heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530358, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530359, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530360, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003477', 'abnormal nerve fiber response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530361, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005403', 'abnormal nerve conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530362, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002473', 'impaired complement classical pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530363, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013806', 'encephalopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530364, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010554', 'shortened HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530365, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530366, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011044', 'increased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530367, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002694', 'abnormal pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530368, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530369, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011045', 'decreased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530370, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005087', 'decreased acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530371, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030924', 'early exit from telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530372, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530373, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003471', 'abnormal summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530374, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010155', 'abnormal intestine physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530375, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004145', 'abnormal muscle electrophysiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530376, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002635', 'reduced sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530377, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001914', 'hemorrhage', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530378, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001533', 'abnormal skeleton physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530379, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001629', 'abnormal heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530380, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530381, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530382, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530383, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530384, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031104', 'crackles', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530385, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004782', 'abnormal surfactant physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530386, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530387, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530388, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530389, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013644', 'increased vertebra maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530390, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008995', 'early reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530391, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031110', 'meningitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530392, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002499', 'chronic inflammation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530393, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001844', 'autoimmune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530394, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001861', 'lung inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530395, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003259', 'nausea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530396, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005001', 'abnormal clonal deletion', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530397, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008005', 'decreased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530398, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530399, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006042', 'increased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530400, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530401, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013625', 'increased femur yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530402, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001867', 'rhinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530403, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004144', 'hypotonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530404, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020147', 'abnormal defecation amount', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530405, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530406, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013632', 'increased femur maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530407, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530408, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530409, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001835', 'abnormal antigen presentation', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530410, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530411, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011717', 'increased interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530412, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020040', 'decreased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530413, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530414, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006043', 'decreased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530415, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001846', 'increased inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530416, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009645', 'crystalluria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530417, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530418, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008664', 'decreased interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530419, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530420, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031128', 'cardiovascular shunt', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530421, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009045', 'muscle tetany', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530422, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020381', 'muscle gating pore current', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530423, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005088', 'increased acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530424, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006080', 'brain ischemia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530425, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005275', 'abnormal skin tensile strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530426, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012011', 'febrile seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530427, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010922', 'alveolitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530428, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530429, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530430, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009697', 'abnormal copulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530431, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010993', 'decreased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530432, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008651', 'increased interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530433, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001596', 'hypotension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530434, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020000', 'abnormal response to antigen', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530435, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002842', 'increased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530436, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006190', 'retina ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530437, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001933', 'abnormal litter size', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530438, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530439, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530440, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008006', 'increased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530441, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530442, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002338', 'abnormal pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530443, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020848', 'abnormal exocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530444, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031090', 'ageusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530445, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013942', 'enthesitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530446, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002896', 'abnormal bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530447, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003762', 'abnormal immune organ physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530448, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030130', 'gum inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530449, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005043', 'defective assembly of class II molecules', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530450, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011926', 'abnormal heart valve physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530451, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009062', 'impaired lectin complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530452, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010072', 'increased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530453, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530454, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530455, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009789', 'decreased susceptibility to bacterial infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530456, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001665', 'chronic diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530457, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530458, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530459, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530460, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530461, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030991', 'optic nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530462, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031089', 'sneezing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530463, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530464, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530465, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530466, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003746', 'stomatitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530467, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008751', 'abnormal interleukin level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530468, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001983', 'abnormal olfactory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530469, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004759', 'decreased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530470, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003820', 'increased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530471, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530472, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530473, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530474, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008272', 'abnormal endochondral bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530475, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002136', 'abnormal kidney physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530476, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530477, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530478, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530479, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020386', 'adipose tissue inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530480, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020845', 'abnormal DNA-templated transcription', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530481, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031480', 'abnormal urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530482, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005044', 'sepsis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530483, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530484, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008702', 'increased interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530485, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530486, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001935', 'decreased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530487, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013556', 'abnormal holocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530488, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530489, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008737', 'abnormal spleen physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530490, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001963', 'abnormal hearing physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530491, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530492, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003900', 'shortened QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530493, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002328', 'abnormal airway resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530494, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031053', 'pleuritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530495, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005435', 'hemoperitoneum', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530496, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003659', 'abnormal lymph circulation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530497, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001634', 'internal hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530498, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011900', 'podocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530499, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011927', 'abnormal cardiac valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530500, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004085', 'abnormal heartbeat', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530501, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002471', 'abnormal complement pathway', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530502, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008564', 'increased interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530503, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0021009', 'abnormal synaptic physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530504, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010520', 'sinoatrial block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530505, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530506, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530507, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009058', 'decreased interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530508, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001947', 'abnormal mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530509, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530510, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530511, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530512, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003560', 'osteoarthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530513, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001542', 'abnormal bone strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530514, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010394', 'decreased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530515, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530516, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002693', 'abnormal pancreas physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530517, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031111', 'meningoencephalitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530518, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013641', 'increased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530519, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010538', 'increased level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530520, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001945', 'bronchoconstriction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530521, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031242', 'increased CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530522, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013136', 'genital discharge', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530523, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530524, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004213', 'abnormal umami taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530525, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002409', 'decreased susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530526, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001858', 'intestinal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530527, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001633', 'poor circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530528, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031247', 'decreased CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530529, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003469', 'decreased single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530530, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530531, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000947', 'convulsive seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530532, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005251', 'blepharitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530533, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008861', 'abnormal hair shedding', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530534, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530535, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530536, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004143', 'muscle hypertonia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530537, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008697', 'decreased interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530538, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530539, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008260', 'abnormal autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530540, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530541, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530542, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530543, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002998', 'abnormal bone remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530544, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012565', 'perivasculitis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530545, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003341', 'chronic pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530546, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004011', 'decreased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530547, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002327', 'abnormal respiratory function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530548, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011013', 'bronchiolectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530549, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004947', 'skin inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530550, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013561', 'abnormal endocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530551, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530552, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013134', 'poor circulation in autopods', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530553, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530554, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000751', 'myopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530555, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530556, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530557, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013638', 'decreased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530558, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003393', 'decreased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530559, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530560, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530561, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010514', 'fragmented QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530562, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011764', 'ureteritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530563, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010552', 'abnormal HV interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530564, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004156', 'abnormal QT variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530565, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530566, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000351', 'increased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530567, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530568, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003483', 'decreased nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530569, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009698', 'heart hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530570, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008682', 'decreased interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530571, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010695', 'abnormal blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530572, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001866', 'nasal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530573, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530574, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530575, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004484', 'abnormal response of heart to induced stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530576, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530577, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530578, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006266', 'decreased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530579, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012197', 'impaired myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530580, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005025', 'abnormal response to infection', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530581, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530582, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530583, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530584, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530585, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530586, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014037', 'stranguria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530587, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001648', 'abnormal apoptosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530588, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530589, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530590, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005515', 'uveitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530591, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011928', 'abnormal mitral valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530592, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006003', 'abnormal large intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530593, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530594, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008666', 'increased interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530595, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530596, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009791', 'increased susceptibility to viral infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530597, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530598, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003470', 'abnormal summary potential', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530599, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002133', 'abnormal respiratory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530600, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003767', 'palate inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530601, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530602, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530603, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003454', 'erythroderma', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530604, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013637', 'increased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530605, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008002', 'hyperchlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530606, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003468', 'increased single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530607, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530608, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008691', 'decreased interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530609, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013459', 'perioral dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530610, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008685', 'decreased interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530611, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031470', 'abnormal macropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530612, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530613, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031240', 'abnormal CSF3 level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530614, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013752', 'stridor', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530615, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530616, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530617, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013479', 'scleritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530618, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002935', 'chronic joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530619, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530620, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031130', 'right-to-left shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530621, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011930', 'abnormal tricuspid valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530622, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013640', 'increased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530623, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530624, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530625, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003278', 'esophageal inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530626, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010753', 'improved mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530627, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000505', 'decreased digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530628, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530629, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012608', 'abnormal complement C5 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530630, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530631, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530632, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005364', 'increased susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530633, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011918', 'abnormal PQ interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530634, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001853', 'heart inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530635, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530636, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010386', 'abnormal urinary bladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530637, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010822', 'pneumothorax', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530638, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008690', 'increased interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530639, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008709', 'decreased interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530640, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530641, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003116', 'rickets', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530642, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530643, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530644, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530645, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011951', 'increased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530646, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003096', 'increased corneal light-scattering', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530647, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530648, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530649, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530650, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001852', 'conjunctivitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530651, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003157', 'impaired muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530652, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011938', 'prolonged PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530653, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530654, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011432', 'decreased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530655, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009732', 'ventricular premature beat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530656, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000503', 'excessive digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530657, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530658, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003340', 'acute pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530659, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011047', 'increased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530660, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001847', 'brain inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530661, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530662, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008713', 'abnormal cytokine level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530663, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003633', 'abnormal nervous system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530664, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530665, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001856', 'myocarditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530666, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530667, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012745', 'abnormal neural crest cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530668, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031306', 'abnormal cartilage physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530669, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530670, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000327', 'hemosiderinuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530671, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003123', 'paternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530672, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030909', 'abnormal melanocyte adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530673, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011048', 'decreased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530674, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001793', 'abnormal susceptibility to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530675, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006335', 'abnormal hearing electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530676, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530677, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010504', 'abnormal RR interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530678, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530679, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530680, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530681, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530682, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008660', 'increased interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530683, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011518', 'abnormal cell chemotaxis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530684, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004796', 'increased anti-histone antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530685, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011420', 'pyuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530686, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011936', 'abnormal PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530687, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011919', 'abnormal R wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530688, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530689, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002254', 'reproductive system inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530690, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004878', 'increased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530691, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008672', 'increased interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530692, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001194', 'dermatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530693, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002419', 'abnormal innate immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530694, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031425', 'enhanced male fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530695, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530696, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530697, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001943', 'abnormal respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530698, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530699, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031471', 'abnormal micropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530700, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530701, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530702, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014030', 'abnormal mucous gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530703, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530704, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005501', 'abnormal skin physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530705, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530706, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003463', 'abnormal single cell response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530707, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011718', 'decreased interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530708, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530709, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002292', 'abnormal gestational length', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530710, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009643', 'abnormal urine homeostasis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530711, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530712, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003280', 'urinary incontinence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530713, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003925', 'abnormal cellular glucose uptake', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530714, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530715, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530716, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013460', 'periocular dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530717, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0009473', 'abnormal skin exfoliation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530718, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002987', 'abnormal urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530719, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530720, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530721, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008565', 'decreased interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530722, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0013478', 'corneal limbitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530723, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004142', 'abnormal muscle tone', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530724, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530725, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008950', 'ventricular tachycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530726, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003865', 'lymph node inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530727, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031223', 'increased CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530728, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530729, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010073', 'decreased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530730, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004122', 'abnormal sinus arrhythmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530731, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003726', 'decreased autoantibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530732, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0000231', 'hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530733, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530734, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0030216', 'tongue muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530735, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530736, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008700', 'decreased interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530737, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003621', 'dysuria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530738, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005532', 'abnormal vascular resistance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530739, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0004780', 'abnormal surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530740, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530741, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003252', 'abnormal bile duct physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530742, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530743, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0005005', 'abnormal self tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530744, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011194', 'abnormal hair follicle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530745, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003929', 'decreased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530746, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031302', 'syncope', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530747, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0001869', 'pancreas inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530748, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008567', 'decreased interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530749, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008007', 'abnormal cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530750, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003866', 'abnormal defecation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530751, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0011566', 'abnormal complement protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530752, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0002161', 'abnormal fertility/fecundity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530753, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530754, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530755, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010636', 'bundle branch block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530756, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003777', 'lip inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530757, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530758, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0031125', 'aspiration pneumonia', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530759, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530760, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0010946', 'hyperpnea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530761, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0008877', 'abnormal DNA methylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(530762, 'HP:0031391', 'Elevated MHC II surface expression', 'MP:0003303', 'peritoneal inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(530763, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0000550', 'abnormal forelimb morphology', 0.4444444444444444, 5.844765229200882, 1.6117299510775347, 'UPHENO:0086635', 'abnormal limb morphology'),
(530764, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0013081', 'autopod open puncture', 0.41935483870967744, 6.296534486251748, 1.6249560621481502, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(530765, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0000572', 'abnormal autopod morphology', 0.5, 6.296534486251748, 1.77433571883279, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(530766, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0013077', 'autopod open abrasion', 0.41935483870967744, 6.296534486251748, 1.6249560621481502, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(530767, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0030881', 'abnormal knee morphology', 0.4827586206896552, 7.553673854641961, 1.909607596132374, 'UPHENO:0003070', 'abnormal leg'),
(530768, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0008909', 'supination', 0.48148148148148145, 6.296534486251748, 1.7411676405905694, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(530769, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0012531', 'delayed limb development', 0.4444444444444444, 5.844765229200882, 1.6117299510775347, 'UPHENO:0086635', 'abnormal limb morphology'),
(530770, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0011685', 'abnormal limb paddle morphology', 0.42857142857142855, 5.844765229200882, 1.5826873929943446, 'UPHENO:0086635', 'abnormal limb morphology'),
(530771, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0003857', 'abnormal hindlimb zeugopod morphology', 0.4827586206896552, 7.553673854641961, 1.909607596132374, 'UPHENO:0003070', 'abnormal leg'),
(530772, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0002109', 'abnormal limb morphology', 0.48, 5.844765229200882, 1.6749588980080745, 'UPHENO:0086635', 'abnormal limb morphology'),
(530773, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0013069', 'limb wound', 0.42857142857142855, 5.844765229200882, 1.5826873929943446, 'UPHENO:0086635', 'abnormal limb morphology'),
(530774, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0000556', 'abnormal hindlimb morphology', 0.5, 7.109295430960158, 1.8853773403433274, 'UPHENO:0086628', 'abnormal hindlimb morphology'),
(530775, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0013080', 'autopod open laceration', 0.41935483870967744, 6.296534486251748, 1.6249560621481502, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(530776, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0031291', 'pes valgus', 0.48148148148148145, 6.296534486251748, 1.7411676405905694, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(530777, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0003800', 'monodactyly', 0.43333333333333335, 6.296534486251748, 1.6518166597342931, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(530778, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0002110', 'abnormal digit morphology', 0.4482758620689655, 6.296534486251748, 1.6800548874579881, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(530779, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0013149', 'macrodactyly', 0.43333333333333335, 6.296534486251748, 1.6518166597342931, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(530780, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0013133', 'pale limbs', 0.46153846153846156, 5.844765229200882, 1.6424323279632769, 'UPHENO:0086635', 'abnormal limb morphology'),
(530781, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0006280', 'abnormal digit development', 0.4444444444444444, 5.844765229200882, 1.6117299510775347, 'UPHENO:0086635', 'abnormal limb morphology'),
(530782, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0013076', 'autopod wound', 0.4482758620689655, 6.296534486251748, 1.6800548874579881, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(530783, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0013078', 'autopod open avulsion', 0.41935483870967744, 6.296534486251748, 1.6249560621481502, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(530784, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0000578', 'ulcerated paws', 0.48148148148148145, 6.296534486251748, 1.7411676405905694, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(530785, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0009049', 'abnormal hallux morphology', 0.45454545454545453, 7.503859459499253, 1.8468473702131685, 'UPHENO:0081575', 'abnormal pes morphology'),
(530786, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0013079', 'autopod open incision', 0.41935483870967744, 6.296534486251748, 1.6249560621481502, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(530787, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0013082', 'autopod closed contusion', 0.41935483870967744, 6.296534486251748, 1.6249560621481502, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(530788, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0006279', 'abnormal limb development', 0.46153846153846156, 5.844765229200882, 1.6424323279632769, 'UPHENO:0086635', 'abnormal limb morphology'),
(530789, 'HP:0032276', 'Prominent subcalcaneal fat pad', 'MP:0003856', 'abnormal hindlimb stylopod morphology', 0.5, 7.553673854641961, 1.943408584760544, 'UPHENO:0003070', 'abnormal leg'),
(530790, 'HP:0007840', 'Long upper eyelashes', 'MP:0031288', 'long eyelid cilia', 0.47619047619047616, 15.192109768632433, 2.689672467989934, 'UPHENO:0072394', 'increased length of the eyelash'),
(530791, 'HP:0006859', 'Posterior leukoencephalopathy', 'MP:0020140', 'increased brain external capsule size', 0.40350877192982454, 10.963291078136551, 2.103279372610325, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(530792, 'HP:0006859', 'Posterior leukoencephalopathy', 'MP:0020141', 'decreased brain external capsule size', 0.40350877192982454, 10.963291078136551, 2.103279372610325, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(530793, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530794, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0003881', 'abnormal nephron morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530795, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011379', 'abnormal kidney outer medulla outer stripe morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530796, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011402', 'renal cast', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530797, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0003942', 'abnormal urinary system development', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(530798, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011361', 'pelvic kidney', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530799, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0000534', 'abnormal ureter morphology', 0.41935483870967744, 7.390401409715969, 1.7604546546762325, 'UPHENO:0087427', 'abnormal renal system morphology'),
(530800, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0012025', 'abnormal comma shaped body morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530801, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0003600', 'ectopic kidney', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530802, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0002135', 'abnormal kidney morphology', 0.5172413793103449, 7.667568053596582, 1.9914777116498774, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530803, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011364', 'abnormal metanephros morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530804, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0002956', 'decreased compensatory renal growth', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530805, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0009641', 'kidney degeneration', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530806, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0003014', 'abnormal kidney medulla morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530807, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530808, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0003197', 'nephrocalcinosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530809, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0003675', 'kidney cyst', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530810, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530811, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0000527', 'abnormal kidney development', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530812, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011797', 'blind ureter', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(530813, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0009640', 'abnormal renal tubule epithelium morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530814, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0004195', 'abnormal kidney calyx morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530815, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0008528', 'polycystic kidney', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530816, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0002706', 'abnormal kidney size', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530817, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0000521', 'abnormal kidney cortex morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530818, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0012026', 'abnormal S-shaped body morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530819, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0008487', 'abnormal mesonephros morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530820, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0003613', 'abnormal kidney medulla development', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530821, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011334', 'abnormal nephrogenic zone morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530822, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011378', 'abnormal kidney outer medulla inner stripe morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530823, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0004192', 'abnormal kidney pyramid morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530824, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0004755', 'abnormal loop of Henle morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530825, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0004754', 'abnormal kidney collecting duct morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530826, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0002829', 'abnormal juxtaglomerular apparatus morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530827, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011332', 'abnormal kidney outer medulla morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530828, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530829, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0009860', 'nephrosclerosis', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530830, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0031002', 'abnormal kidney glycogen level', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530831, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0012024', 'abnormal nephron morphogenesis', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530832, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0002955', 'increased compensatory renal growth', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530833, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011347', 'abnormal kidney medullary ray morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530834, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42857142857142855, 7.390401409715969, 1.7796951676841382, 'UPHENO:0087427', 'abnormal renal system morphology'),
(530835, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011383', 'abnormal kidney capsule morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530836, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011381', 'abnormal kidney lobe morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530837, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0004969', 'pale kidney', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530838, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011333', 'abnormal kidney inner medulla morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530839, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0002703', 'abnormal renal tubule morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530840, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011767', 'ureterocele', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(530841, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530842, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0003985', 'renal fibrosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530843, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011382', 'abnormal kidney lobule morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530844, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0005360', 'urolithiasis', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(530845, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011534', 'granular kidney', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530846, 'HP:0033132', 'Renal cortical hyperechogenicity', 'MP:0011337', 'abnormal perihilar interstitium morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(530847, 'HP:0000858', 'Irregular menstruation', 'MP:0003699', 'abnormal female reproductive system physiology', 0.42105263157894735, 10.972941248170269, 2.1494617439496966, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
(530848, 'HP:0000858', 'Irregular menstruation', 'MP:0002292', 'abnormal gestational length', 0.41025641025641024, 10.972941248170269, 2.1217255916891866, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
(530849, 'HP:0000858', 'Irregular menstruation', 'MP:0009661', 'abnormal pregnancy', 0.41025641025641024, 10.972941248170269, 2.1217255916891866, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
(530850, 'HP:0000858', 'Irregular menstruation', 'MP:0009344', 'abnormal ovulation cycle', 0.41025641025641024, 10.972941248170269, 2.1217255916891866, 'UPHENO:0002262', 'abnormality of female reproductive system physiology'),
(530851, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0013366', 'adrenal gland atrophy', 0.5106382978723404, 14.87018167374507, 2.755591453560134, 'UPHENO:0069075', 'decreased size of the adrenal gland'),
(530852, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0008300', 'enlarged adrenal medulla', 0.4375, 13.799792345853671, 2.4571139882616313, 'UPHENO:0086668', 'abnormal adrenal medulla morphology'),
(530853, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0003113', 'small parathyroid gland', 0.425531914893617, 7.914822368502075, 1.8352137528123316, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(530854, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0000734', 'muscle hypoplasia', 0.41304347826086957, 8.202005804774931, 1.8405936559491016, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(530855, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0000642', 'enlarged adrenal glands', 0.44680851063829785, 12.732678149995134, 2.385176924388655, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(530856, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0009169', 'pancreatic islet hypoplasia', 0.41818181818181815, 8.202005804774931, 1.852006938480147, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(530857, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0008301', 'adrenal medulla hyperplasia', 0.4117647058823529, 13.799792345853671, 2.383750707714207, 'UPHENO:0086668', 'abnormal adrenal medulla morphology'),
(530858, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0000640', 'adrenal gland hypoplasia', 0.6222222222222222, 15.87018167374507, 3.142416221334794, 'UPHENO:0081179', 'adrenal gland hypoplasia'),
(530859, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0002768', 'small adrenal glands', 0.5454545454545454, 14.87018167374507, 2.8479831786159004, 'UPHENO:0069075', 'decreased size of the adrenal gland'),
(530860, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0000071', 'axial skeleton hypoplasia', 0.40425531914893614, 8.202005804774931, 1.8209075963021069, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(530861, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0003499', 'thyroid gland hypoplasia', 0.46938775510204084, 8.202005804774931, 1.9621215793210198, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(530862, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0020144', 'small adrenal gland x-zone', 0.4230769230769231, 11.397693902282326, 2.19592833816366, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(530863, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0002951', 'small thyroid gland', 0.425531914893617, 7.914822368502075, 1.8352137528123316, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(530864, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0008302', 'thin adrenal cortex', 0.44, 11.397693902282326, 2.2394162893495757, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(530865, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0009078', 'adrenal gland hyperplasia', 0.42, 12.732678149995134, 2.312514826546623, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(530866, 'HP:0008239', 'Adrenal medullary hypoplasia', 'MP:0003494', 'parathyroid hypoplasia', 0.46938775510204084, 8.202005804774931, 1.9621215793210198, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(530867, 'HP:0034229', 'Distal aortic arch hypoplasia', 'MP:0010541', 'aorta hypoplasia', 0.45454545454545453, 9.58108497132508, 2.0868729293681447, 'UPHENO:0076809', 'abnormal aorta morphology'),
(530868, 'HP:0034229', 'Distal aortic arch hypoplasia', 'MP:0010469', 'ascending aorta hypoplasia', 0.4482758620689655, 11.562753148552822, 2.276686876924045, 'UPHENO:0087172', 'abnormal thoracic aorta morphology'),
(530869, 'HP:0034229', 'Distal aortic arch hypoplasia', 'MP:0010474', 'descending aorta hypoplasia', 0.43859649122807015, 9.58108497132508, 2.049934206403019, 'UPHENO:0076809', 'abnormal aorta morphology'),
(530870, 'HP:0034229', 'Distal aortic arch hypoplasia', 'MP:0010543', 'aorta tubular hypoplasia', 0.44642857142857145, 9.58108497132508, 2.068156202148283, 'UPHENO:0076809', 'abnormal aorta morphology'),
(530871, 'HP:0034229', 'Distal aortic arch hypoplasia', 'MP:0010485', 'aortic arch hypoplasia', 0.5178571428571429, 15.607147267911275, 2.842933817785985, 'UPHENO:0081085', 'arch of aorta hypoplasia'),
(530872, 'HP:0034229', 'Distal aortic arch hypoplasia', 'MP:0010528', 'pulmonary vein hypoplasia', 0.42105263157894735, 9.15319077934013, 1.9631543660612423, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(530873, 'HP:0034229', 'Distal aortic arch hypoplasia', 'MP:0010460', 'pulmonary artery hypoplasia', 0.42857142857142855, 9.15319077934013, 1.9806049702776742, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(530874, 'HP:0034229', 'Distal aortic arch hypoplasia', 'MP:0010458', 'pulmonary trunk hypoplasia', 0.41818181818181815, 8.202005804774931, 1.852006938480147, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(530875, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030161', 'absent auditory bulla', 0.5161290322580645, 7.8051695233081215, 2.0071060242735457, 'UPHENO:0076730', 'abnormal ear morphology'),
(530876, 'HP:0031703', 'Abnormal ear morphology', 'MP:0003677', 'abnormal ear lobe morphology', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(530877, 'HP:0031703', 'Abnormal ear morphology', 'MP:0020305', 'abnormal horn pigmentation', 0.45161290322580644, 4.6730878730104815, 1.4527308014080145, 'UPHENO:0087907', 'abnormal head morphology'),
(530878, 'HP:0031703', 'Abnormal ear morphology', 'MP:0003737', 'ossification of pinnae', 0.48484848484848486, 7.8051695233081215, 1.9453340631782279, 'UPHENO:0076730', 'abnormal ear morphology'),
(530879, 'HP:0031703', 'Abnormal ear morphology', 'MP:0013102', 'ear open puncture', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(530880, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030078', 'synotia', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(530881, 'HP:0031703', 'Abnormal ear morphology', 'MP:0011238', 'abnormal inner ear development', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(530882, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030096', 'abnormal periauricular region morphology', 0.42424242424242425, 4.6730878730104815, 1.4080206418742023, 'UPHENO:0087907', 'abnormal head morphology'),
(530883, 'HP:0031703', 'Abnormal ear morphology', 'MP:0020304', 'abnormal horn morphology', 0.4827586206896552, 4.6730878730104815, 1.5019898321680125, 'UPHENO:0087907', 'abnormal head morphology'),
(530884, 'HP:0031703', 'Abnormal ear morphology', 'MP:0006018', 'abnormal tympanic membrane morphology', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(530885, 'HP:0031703', 'Abnormal ear morphology', 'MP:0003330', 'abnormal auditory tube morphology', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(530886, 'HP:0031703', 'Abnormal ear morphology', 'MP:0013114', 'greasy head/neck', 0.45161290322580644, 4.6730878730104815, 1.4527308014080145, 'UPHENO:0087907', 'abnormal head morphology'),
(530887, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030098', 'periorbital fullness', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(530888, 'HP:0031703', 'Abnormal ear morphology', 'MP:0020290', 'floppy ears', 0.48484848484848486, 7.8051695233081215, 1.9453340631782279, 'UPHENO:0076730', 'abnormal ear morphology'),
(530889, 'HP:0031703', 'Abnormal ear morphology', 'MP:0002102', 'abnormal ear morphology', 0.5517241379310345, 7.8051695233081215, 2.0751627470279908, 'UPHENO:0076730', 'abnormal ear morphology'),
(530890, 'HP:0031703', 'Abnormal ear morphology', 'MP:0012719', 'abnormal neck morphology', 0.41379310344827586, 4.656469875639396, 1.3880976626139216, 'UPHENO:0086589', 'abnormal craniocervical region morphology'),
(530891, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030246', 'abnormal cheek morphology', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(530892, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030324', 'abnormal anterior head development', 0.4827586206896552, 4.6730878730104815, 1.5019898321680125, 'UPHENO:0087907', 'abnormal head morphology'),
(530893, 'HP:0031703', 'Abnormal ear morphology', 'MP:0003938', 'abnormal ear development', 0.5333333333333333, 7.8051695233081215, 2.040283578108118, 'UPHENO:0076730', 'abnormal ear morphology'),
(530894, 'HP:0031703', 'Abnormal ear morphology', 'MP:0009901', 'abnormal frontonasal prominence morphology', 0.42424242424242425, 4.6730878730104815, 1.4080206418742023, 'UPHENO:0087907', 'abnormal head morphology'),
(530895, 'HP:0031703', 'Abnormal ear morphology', 'MP:0003935', 'abnormal craniofacial development', 0.46153846153846156, 4.656469875639396, 1.4659945233877234, 'UPHENO:0086589', 'abnormal craniocervical region morphology'),
(530896, 'HP:0031703', 'Abnormal ear morphology', 'MP:0011496', 'abnormal head size', 0.42424242424242425, 4.6730878730104815, 1.4080206418742023, 'UPHENO:0087907', 'abnormal head morphology'),
(530897, 'HP:0031703', 'Abnormal ear morphology', 'MP:0004427', 'abnormal vestibular labyrinth morphology', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(530898, 'HP:0031703', 'Abnormal ear morphology', 'MP:0002859', 'abnormal inner ear canal fusion', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(530899, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030413', 'tympanic membrane retraction', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(530900, 'HP:0031703', 'Abnormal ear morphology', 'MP:0002092', 'abnormal eye morphology', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(530901, 'HP:0031703', 'Abnormal ear morphology', 'MP:0003681', 'protruding ear lobes', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(530902, 'HP:0031703', 'Abnormal ear morphology', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 7.171824267787784, 1.7226872673685047, 'UPHENO:0002903', 'abnormal ear'),
(530903, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030187', 'abnormal epitympanic recess morphology', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(530904, 'HP:0031703', 'Abnormal ear morphology', 'MP:0006033', 'abnormal external auditory canal morphology', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(530905, 'HP:0031703', 'Abnormal ear morphology', 'MP:0003743', 'abnormal facial morphology', 0.4666666666666667, 4.6730878730104815, 1.4767445076038797, 'UPHENO:0087907', 'abnormal head morphology'),
(530906, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030154', 'abnormal tympanic cavity morphology', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(530907, 'HP:0031703', 'Abnormal ear morphology', 'MP:0000026', 'abnormal inner ear morphology', 0.5, 7.8051695233081215, 1.975496079888305, 'UPHENO:0076730', 'abnormal ear morphology'),
(530908, 'HP:0031703', 'Abnormal ear morphology', 'MP:0002177', 'abnormal outer ear morphology', 0.5, 7.8051695233081215, 1.975496079888305, 'UPHENO:0076730', 'abnormal ear morphology'),
(530909, 'HP:0031703', 'Abnormal ear morphology', 'MP:0000432', 'abnormal head morphology', 0.5185185185185185, 4.6730878730104815, 1.5566253887240338, 'UPHENO:0087907', 'abnormal head morphology'),
(530910, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030313', 'abnormal face development', 0.4375, 4.6730878730104815, 1.4298517211382744, 'UPHENO:0087907', 'abnormal head morphology'),
(530911, 'HP:0031703', 'Abnormal ear morphology', 'MP:0013100', 'ear open incision', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(530912, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030321', 'abnormal tegmen tympani morphology', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(530913, 'HP:0031703', 'Abnormal ear morphology', 'MP:0000443', 'abnormal snout morphology', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(530914, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030178', 'abnormal scalp morphology', 0.4666666666666667, 4.6730878730104815, 1.4767445076038797, 'UPHENO:0087907', 'abnormal head morphology'),
(530915, 'HP:0031703', 'Abnormal ear morphology', 'MP:0013099', 'ear open avulsion', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(530916, 'HP:0031703', 'Abnormal ear morphology', 'MP:0000023', 'abnormal ear position', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(530917, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030160', 'abnormal auditory bulla morphology', 0.5333333333333333, 7.8051695233081215, 2.040283578108118, 'UPHENO:0076730', 'abnormal ear morphology'),
(530918, 'HP:0031703', 'Abnormal ear morphology', 'MP:0012176', 'abnormal head development', 0.5, 4.6730878730104815, 1.528575786968131, 'UPHENO:0087907', 'abnormal head morphology'),
(530919, 'HP:0031703', 'Abnormal ear morphology', 'MP:0000020', 'scaly ears', 0.48484848484848486, 7.8051695233081215, 1.9453340631782279, 'UPHENO:0076730', 'abnormal ear morphology'),
(530920, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030228', 'absent tubotympanic recess', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(530921, 'HP:0031703', 'Abnormal ear morphology', 'MP:0013101', 'ear open laceration', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(530922, 'HP:0031703', 'Abnormal ear morphology', 'MP:0031285', 'external auditory canal stenosis', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(530923, 'HP:0031703', 'Abnormal ear morphology', 'MP:0031305', 'preauricular skin tag', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(530924, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030031', 'abnormal forehead morphology', 0.42424242424242425, 4.6730878730104815, 1.4080206418742023, 'UPHENO:0087907', 'abnormal head morphology'),
(530925, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030095', 'abnormal midface morphology', 0.4375, 4.6730878730104815, 1.4298517211382744, 'UPHENO:0087907', 'abnormal head morphology'),
(530926, 'HP:0031703', 'Abnormal ear morphology', 'MP:0004426', 'abnormal cochlear labyrinth morphology', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(530927, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030092', 'abnormal outer ear helix morphology', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(530928, 'HP:0031703', 'Abnormal ear morphology', 'MP:0003682', 'linear crease in ear lobe', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(530929, 'HP:0031703', 'Abnormal ear morphology', 'MP:0000052', 'early ear unfolding', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(530930, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030097', 'preauricular pit', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(530931, 'HP:0031703', 'Abnormal ear morphology', 'MP:0000035', 'abnormal membranous labyrinth morphology', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(530932, 'HP:0031703', 'Abnormal ear morphology', 'MP:0006011', 'abnormal endolymphatic duct morphology', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(530933, 'HP:0031703', 'Abnormal ear morphology', 'MP:0013098', 'ear open abrasion', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(530934, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030227', 'abnormal tubotympanic recess morphology', 0.48484848484848486, 7.8051695233081215, 1.9453340631782279, 'UPHENO:0076730', 'abnormal ear morphology'),
(530935, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030226', 'middle ear polyps', 0.48484848484848486, 7.8051695233081215, 1.9453340631782279, 'UPHENO:0076730', 'abnormal ear morphology'),
(530936, 'HP:0031703', 'Abnormal ear morphology', 'MP:0006287', 'inner ear cyst', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(530937, 'HP:0031703', 'Abnormal ear morphology', 'MP:0030410', 'middle ear effusion', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(530938, 'HP:0031703', 'Abnormal ear morphology', 'MP:0020900', 'abnormal middle ear epithelium morphology', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(530939, 'HP:0031703', 'Abnormal ear morphology', 'MP:0000428', 'abnormal craniofacial morphology', 0.48, 4.656469875639396, 1.4950269363148312, 'UPHENO:0086589', 'abnormal craniocervical region morphology'),
(530940, 'HP:0031703', 'Abnormal ear morphology', 'MP:0002729', 'abnormal inner ear canal morphology', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(530941, 'HP:0031703', 'Abnormal ear morphology', 'MP:0003712', 'raised ear position', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(530942, 'HP:0031703', 'Abnormal ear morphology', 'MP:0013103', 'ear closed contusion', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(530943, 'HP:0031703', 'Abnormal ear morphology', 'MP:0000049', 'abnormal middle ear morphology', 0.5, 7.8051695233081215, 1.975496079888305, 'UPHENO:0076730', 'abnormal ear morphology'),
